Can	O	O
administration	O	O
reduced	O	O
D	O	O
h	O	O
and	O	O
increased	O	O
D	O	O
anti	O	O
.	O	O
Moreover	O	O
,	O	O
the	O	O
magnitude	O	O
of	O	O
anti	O	O
in	O	O
the	O	O
controls	O	O
,	O	O
and	O	O
in	O	O
the	O	O
patients	O	O
after	O	O
can	O	O
administration	O	O
,	O	O
positively	O	O
correlated	O	O
with	O	O
W	O	O
performance	O	O
.	O	O
The	O	O
finding	O	O
that	O	O
D	O	O
brain	O	O
connectivity	O	O
is	O	O
plastic	O	O
may	O	O
have	O	O
implications	O	O
for	O	O
future	O	O
p	O	O
development	O	O
,	O	O
as	O	O
treatment	O	O
efficacy	O	O
could	O	O
be	O	O
assessed	O	O
through	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
to	O	O
normal	O	O
underlying	O	O
circuit	O	O
d	O	O
.	O	O
Experimental	B-StudyMethod	B-E
Materials	I-StudyMethod	B-E
and	I-StudyMethod	I-E
Method	I-StudyMethod	I-E
Sub	O	I-E
Twelve	O	O
patients	B-Schizophrenia	O
with	I-Schizophrenia	O
SC	I-Schizophrenia	B-E
and	O	O
C	B-CannabisAbuse	O
and	O	O
twelve	O	O
healthy	B-NoKnownDisorder	O
control	I-NoKnownDisorder	O
subjects	I-NoKnownDisorder	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O
As	O	O
previously	O	O
described	O	O
in	O	O
all	O	O
patients	O	O
were	O	O
recruited	O	O
from	O	O
community	O	O
mental	O	O
health	O	O
centers	O	O
and	O	O
met	O	O
criteria	O	O
for	O	O
SC	B-Schizophrenia	O
and	O	O
C	B-CannabisAbuse	O
,	I-CannabisAbuse	O
defined	I-CannabisAbuse	O
as	I-CannabisAbuse	O
either	I-CannabisAbuse	O
current	I-CannabisAbuse	O
cannabis	I-CannabisAbuse	O
abuse	I-CannabisAbuse	O
or	I-CannabisAbuse	O
dependence	I-CannabisAbuse	O
with	I-CannabisAbuse	O
use	I-CannabisAbuse	O
within	I-CannabisAbuse	O
the	I-CannabisAbuse	O
past	I-CannabisAbuse	O
month	I-CannabisAbuse	O
prior	I-CannabisAbuse	O
to	I-CannabisAbuse	O
study	I-CannabisAbuse	O
enrollment	I-CannabisAbuse	O
,	O	O
as	O	O
determined	O	O
by	O	O
the	O	O
Structure	B-StructuredClinicalInterviewforDSMDisorders	B-E
Clinical	I-StructuredClinicalInterviewforDSMDisorders	I-E
Interview	I-StructuredClinicalInterviewforDSMDisorders	I-E
for	I-StructuredClinicalInterviewforDSMDisorders	I-E
DS	I-StructuredClinicalInterviewforDSMDisorders	I-E
(	I-StructuredClinicalInterviewforDSMDisorders	I-E
SC	I-StructuredClinicalInterviewforDSMDisorders	I-E
)	I-StructuredClinicalInterviewforDSMDisorders	I-E
.	O	O
While	O	O
a	O	O
history	O	O
of	O	O
alcohol	O	O
or	O	O
substance	O	O
use	O	O
(	O	O
other	O	O
than	O	O
cannabis	O	O
)	O	O
was	O	O
permitted	O	O
in	O	O
the	O	O
patient	O	O
group	O	O
,	O	O
they	O	O
were	O	O
required	O	O
to	O	O
be	O	O
alcohol	O	O
and	O	O
substance	O	O
free	O	O
for	O	O
a	O	O
minimum	O	O
of	O	O
seven	O	O
days	O	O
prior	O	O
to	O	O
testing	O	O
and	O	O
scanning	O	O
.	O	O
Tobacco	O	O
users	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
,	O	O
since	O	O
up	O	O
to	O	O
90	O	O
of	O	O
patients	O	O
with	O	O
SC	O	O
smoke	O	O
cigarettes	O	O
.	O	O
All	O	O
patients	O	O
were	O	O
on	O	O
a	O	O
stable	O	O
dose	O	O
of	O	O
anti	O	O
medication	O	O
for	O	O
a	O	O
minimum	O	O
of	O	O
one	O	O
month	O	O
prior	O	O
to	O	O
study	O	O
participation	O	O
.	O	O
Pat	O	O
taking	O	O
c	O	O
were	O	O
excluded	O	O
given	O	O
its	O	O
proposed	O	O
ability	O	O
to	O	O
decrease	O	O
alcohol	O	O
and	O	O
cannabis	O	O
use	O	O
in	O	O
patients	O	O
with	O	O
SC	O	O
.	O	O
Ph	O	O
for	O	O
addiction	O	O
,	O	O
mental	O	O
re	O	O
,	O	O
a	O	O
history	O	O
of	O	O
head	O	O
injury	O	O
,	O	O
or	O	O
factors	O	O
that	O	O
con	O	O
the	O	O
use	O	O
of	O	O
f	O	O
served	O	O
as	O	O
exclusion	O	O
criteria	O	O
.	O	O
The	B-NoKnownDisorder	O
healthy	I-NoKnownDisorder	B-E
control	I-NoKnownDisorder	I-E
group	I-NoKnownDisorder	I-E
was	O	O
matched	O	O
to	O	O
the	O	O
patient	O	O
sample	O	O
on	O	O
age	O	O
,	O	O
gender	O	O
and	O	O
handed	O	O
.	O	O
In	O	O
addition	O	O
to	O	O
the	O	O
exclusion	O	O
criteria	O	O
noted	O	O
above	O	O
,	O	O
controls	O	O
were	O	O
excluded	O	O
if	O	O
they	O	O
had	O	O
any	O	O
current	O	O
or	O	O
history	O	O
of	O	O
Axis	O	O
I	O	O
or	O	O
II	O	O
disorders	O	O
,	O	O
including	O	O
any	O	O
substance	O	B-E
use	O	O
disorder	O	O
.	O	O
A	O	O
signed	O	O
informed	O	O
consent	O	O
was	O	O
obtained	O	O
from	O	O
participants	O	O
prior	O	O
to	O	O
initiation	O	O
of	O	O
the	O	O
study	O	O
.	O	O
The	O	O
protocol	O	O
was	O	O
approved	O	O
by	O	O
the	O	O
Committee	O	O
for	O	O
the	O	O
Protection	O	O
of	O	O
Human	O	O
Sub	O	O
(	O	O
I	O	O
)	O	O
at	O	O
Dartmouth	O	O
College	O	O
.	O	O
Further	O	O
details	O	O
of	O	O
the	O	O
study	O	O
design	O	O
were	O	O
reviewed	O	O
in	O	O
.	O	O
Study	B-StudyMethod	O
Design	I-StudyMethod	B-E
and	I-StudyMethod	I-E
Pro	I-StudyMethod	I-E
Part	O	O
refrain	O	O
from	O	O
substance	O	O
use	O	O
(	O	O
except	O	O
for	O	O
tobacco	O	O
or	O	O
ca	O	O
)	O	O
for	O	O
the	O	O
duration	O	O
of	O	O
the	O	O
study	O	O
.	O	O
Sub	O	O
completed	O	O
a	O	O
‘	O	O
base	O	O
’	O	O
session	O	O
(	O	O
T	O	O
)	O	O
,	O	O
and	O	O
then	O	O
returned	O	O
one	O	O
week	O	O
later	O	O
for	O	O
a	O	O
second	O	O
scan	O	O
session	O	O
(	O	O
T	O	O
)	O	O
during	O	O
which	O	O
patients	O	O
were	O	O
random	O	O
to	O	O
one	O	O
of	O	O
two	O	O
double	O	O
can	O	O
intervention	O	O
groups	O	O
:	O	O
an	O	O
oral	O	O
T	O	O
group	O	O
(	O	O
N	O	O
=	O	O
6	O	O
)	O	O
or	O	O
an	O	O
active	O	O
cannabis	O	O
cigarette	O	O
(	O	O
3	O	O
T	O	O
)	O	O
group	O	O
(	O	O
N	O	O
=	O	O
6	O	O
)	O	O
.	O	O
Those	O	O
in	O	O
the	O	O
T	O	B-E
group	O	O
were	O	O
given	O	O
a	O	O
15	O	O
T	O	O
pill	O	O
(	O	O
three	O	O
hours	O	O
prior	O	O
to	O	O
scanning	O	O
)	O	O
and	O	O
then	O	O
smoked	O	O
a	O	O
place	O	O
cannabis	O	O
cigarette	O	O
immediately	O	O
prior	O	O
to	O	O
scanning	O	O
.	O	O
Those	O	O
in	O	O
the	O	O
cannabis	O	O
group	O	O
were	O	O
given	O	O
a	O	O
place	O	O
pill	O	O
(	O	O
3	O	O
hours	O	O
prior	O	O
to	O	O
scanning	O	O
)	O	O
and	O	O
then	O	O
smoked	O	O
an	O	O
active	O	O
3	O	O
T	O	O
cannabis	O	O
cigarette	O	O
immediately	O	O
before	O	O
scanning	O	O
.	O	O
S	O	O
took	O	O
place	O	O
in	O	O
a	O	O
smoking	O	O
chamber	O	O
within	O	O
the	O	O
scan	O	O
bay	O	O
,	O	O
immediately	O	O
prior	O	O
to	O	O
scanning	O	O
(	O	O
Figure	O	O
1	O	O
)	O	O
.	O	O
Pat	O	O
who	O	O
were	O	O
tobacco	O	O
smoke	O	O
were	O	O
asked	O	O
to	O	O
smoke	O	O
a	O	O
cigarette	O	O
90	O	O
minutes	O	O
prior	O	O
to	O	O
scanning	O	O
,	O	O
based	O	O
upon	O	O
p	O	O
of	O	O
smoked	O	O
tobacco	O	O
.	O	O
Further	O	O
details	O	O
can	O	O
be	O	O
found	O	O
in	O	O
.	O	O
Health	B-NoKnownDisorder	O
control	I-NoKnownDisorder	I-E
participants	I-NoKnownDisorder	O
followed	O	O
the	O	O
same	O	O
study	O	O
protocol	O	O
,	O	O
but	O	O
did	O	O
not	O	O
receive	O	O
any	O	O
p	O	O
intervention	O	O
during	O	O
T	O	O
.	O	O
In	O	O
order	O	O
to	O	O
assist	O	O
patients	O	O
in	O	O
remaining	O	O
a	O	O
from	O	O
substance	O	O
use	O	O
for	O	O
the	O	O
duration	O	O
of	O	O
the	O	O
study	O	O
,	O	O
they	O	O
were	O	O
assessed	O	O
three	O	O
times	O	O
in	O	O
the	O	O
week	O	O
prior	O	O
to	O	O
each	O	O
scan	O	O
session	O	O
.	O	O
Each	O	O
time	O	O
,	O	O
they	O	O
were	O	O
screened	O	O
for	O	O
substance	O	O
use	O	O
with	O	O
an	O	O
alcohol	O	O
breath	O	O
,	O	O
a	O	O
Time	B-SubstanceUseScale	O
Follow	I-SubstanceUseScale	O
interview	I-SubstanceUseScale	O
,	O	O
and	O	O
a	O	O
urine	O	O
toxic	O	O
screen	O	O
(	O	O
To	O	O
Drug	O	O
Screen	O	O
cup	O	O
;	O	O
C	O	O
,	O	O
Sand	O	O
Diego	O	O
,	O	O
CA	O	O
)	O	O
.	O	O
Pat	O	O
were	O	O
discontinued	O	O
from	O	O
the	O	O
study	O	O
if	O	O
screening	O	O
suggested	O	O
substance	O	O
use	O	O
during	O	O
study	O	O
participation	O	O
.	O	O
T	O	O
and	O	O
s	O	O
measures	O	O
V	O	O
blood	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
patients	O	O
at	O	O
T	O	O
,	O	O
in	O	O
the	O	O
morning	O	O
of	O	O
the	O	O
T	O	O
session	O	O
,	O	O
immediately	O	O
prior	O	O
to	O	O
f	B-FunctionalMagneticResonanceImaging	O
scanning	I-FunctionalMagneticResonanceImaging	O
,	O	O
and	O	O
before	O	O
cognitive	O	O
testing	O	O
(	O	O
Figure	O	O
1	O	O
)	O	O
.	O	O
The	O	B-E
Mari	B-SubstanceCravingScale	B-E
C	I-SubstanceCravingScale	I-E
Question	I-SubstanceCravingScale	I-E
(	I-SubstanceCravingScale	I-E
MC	I-SubstanceCravingScale	I-E
)	I-SubstanceCravingScale	I-E
,	O	I-E
Can	B-SubstanceCravingScale	B-E
With	I-SubstanceCravingScale	I-E
Scale	I-SubstanceCravingScale	I-E
(	I-SubstanceCravingScale	I-E
CW	I-SubstanceCravingScale	I-E
)	I-SubstanceCravingScale	I-E
,	O	I-E
and	O	I-E
Po	B-PositiveandNegativeSyndromeScale	B-E
and	I-PositiveandNegativeSyndromeScale	I-E
N	I-PositiveandNegativeSyndromeScale	I-E
S	I-PositiveandNegativeSyndromeScale	I-E
Scale	I-PositiveandNegativeSyndromeScale	I-E
(	I-PositiveandNegativeSyndromeScale	I-E
PA	I-PositiveandNegativeSyndromeScale	I-E
)	I-PositiveandNegativeSyndromeScale	I-E
were	O	O
administered	O	O
to	O	O
assess	O	O
for	O	O
change	O	O
in	O	O
marijuana	O	O
c	O	O
,	O	O
withdrawal	O	O
,	O	O
and	O	O
positive	O	O
and	O	O
negative	O	O
symptoms	O	O
.	O	O
Change	O	O
in	O	O
these	O	O
measures	O	O
was	O	O
analyzed	O	O
using	O	O
repeated	O	O
measures	O	O
analysis	O	O
of	O	O
variance	O	O
(	O	O
AN	O	O
)	O	O
with	O	O
group	O	O
as	O	O
the	O	O
between	O	O
group	O	O
factor	O	O
and	O	O
time	O	O
as	O	O
the	O	O
within	O	O
factor	O	O
,	O	O
followed	O	O
by	O	O
post	O	O
analysis	O	O
using	O	O
Tu	O	O
’	O	O
s	O	O
L	O	O
test	O	O
for	O	O
pair	O	O
comparisons	O	O
.	O	O
Working	O	O
memory	O	O
performance	O	O
To	O	O
assess	O	O
for	O	O
change	O	O
in	O	O
working	O	O
memory	O	O
performance	O	O
induced	O	O
by	O	O
cannabis	O	O
and	O	O
T	O	O
,	O	O
the	B-NeurocognitiveTest	O
We	I-NeurocognitiveTest	B-E
Adult	I-NeurocognitiveTest	I-E
Intelligence	I-NeurocognitiveTest	I-E
Scale	I-NeurocognitiveTest	I-E
(	I-NeurocognitiveTest	I-E
WA	I-NeurocognitiveTest	I-E
)	I-NeurocognitiveTest	I-E
III	I-NeurocognitiveTest	O
Letter	I-NeurocognitiveTest	I-E
Number	I-NeurocognitiveTest	I-E
Se	I-NeurocognitiveTest	I-E
Test	I-NeurocognitiveTest	O
was	O	O
administered	O	O
approximately	O	O
30	O	O
minutes	O	O
after	O	O
the	O	O
end	O	O
of	O	O
the	O	O
scanning	O	O
sessions	O	O
at	O	O
T	O	O
and	O	O
T	O	O
.	O	O
This	O	O
test	O	O
was	O	O
selected	O	O
because	O	O
of	O	O
availability	O	O
of	O	O
alternate	O	O
forms	O	O
and	O	O
thus	O	O
its	O	O
app	O	O
to	O	O
the	O	O
repeated	O	O
study	O	O
design	O	O
.	O	O
The	O	O
change	O	O
in	O	O
W	O	O
performance	O	O
in	O	O
patients	O	O
was	O	O
evaluated	O	O
with	O	O
a	O	O
repeated	O	O
AN	O	O
.	O	O
A	O	O
correlation	O	O
analysis	O	O
between	O	O
W	O	O
performance	O	O
and	O	O
the	O	O
magnitude	O	O
of	O	O
D	O	O
anti	O	O
was	O	O
performed	O	O
between	O	O
the	O	O
MP	O	O
component	O	O
of	O	O
the	O	O
D	O	O
and	O	O
the	O	O
DL	O	O
component	O	O
of	O	O
the	O	O
EC	O	O
.	O	O
f	B-FunctionalMagneticResonanceImaging	B-E
data	I-FunctionalMagneticResonanceImaging	O
acquisition	I-FunctionalMagneticResonanceImaging	O
f	I-FunctionalMagneticResonanceImaging	B-E
data	I-FunctionalMagneticResonanceImaging	I-E
were	O	O
obtained	O	O
using	O	O
a	O	O
3	O	O
Phillips	O	O
A	O	O
f	O	O
scan	O	O
with	O	O
an	O	O
8	O	O
channel	O	O
head	O	O
coil	O	O
.	O	O
Each	O	O
subject	O	O
underwent	O	O
two	O	O
8	O	O
-	O	O
minute	O	O
resting	B-RestingStateImaging	O
scan	I-RestingStateImaging	O
during	O	O
the	O	O
study	O	O
with	O	O
eyes	O	O
open	O	O
,	O	O
one	O	O
at	O	O
base	O	O
(	O	O
T	O	O
)	O	O
,	O	O
and	O	O
the	O	O
second	O	O
during	O	O
the	O	O
‘	O	O
intervention	O	O
’	O	O
session	O	O
(	O	O
T	O	O
)	O	O
.	O	O
Further	O	O
details	O	O
can	O	O
be	O	O
found	O	O
in	O	O
.	O	O
The	O	O
resting	B-RestingStateImaging	B-E
state	I-RestingStateImaging	I-E
data	I-RestingStateImaging	I-E
were	O	O
acquired	O	O
transverse	O	O
to	O	O
the	O	O
AC	O	O
plane	O	O
,	O	O
with	O	O
a	B-T2WeightedImaging	O
T	I-T2WeightedImaging	B-E
*	I-T2WeightedImaging	I-E
-	I-T2WeightedImaging	I-E
weighted	I-T2WeightedImaging	I-E
single	O	O
shot	O	I-E
echo	O	I-E
plan	O	I-E
imaging	O	I-E
(	O	I-E
EP	O	I-E
)	O	I-E
pulse	O	O
sequence	O	O
designed	O	O
to	O	O
measure	O	O
whole	O	O
brain	O	O
B	O	O
contrast	O	O
with	O	O
optimal	O	O
temporal	O	O
and	O	O
spatial	O	O
resolution	O	O
[	O	O
repetition	O	O
time	O	O
(	O	O
T	O	O
)	O	O
=	O	O
2000	O	O
;	O	O
echo	O	O
time	O	O
(	O	O
T	O	O
)	O	O
=	O	O
30	O	O
;	O	O
F	O	O
angle	O	O
(	O	O
FA	O	O
)	O	O
=	O	O
90	O	O
degrees	O	O
;	O	O
field	O	O
of	O	O
view	O	O
(	O	O
F	O	O
)	O	O
=	O	O
240	O	O
mm	O	O
;	O	O
S	O	O
thickness	O	O
=	O	O
2	O	O
mm	O	O
;	O	O
S	O	O
skip	O	O
0	O	O
;	O	O
S	O	O
location	O	O
=	O	O
Pat	O	O
.	O	O
S	O	O
;	O	O
Fat	O	O
sat	O	O
=	O	O
SP	O	O
;	O	O
Rep	O	O
=	O	O
240	O	O
;	O	O
NE	O	O
=	O	O
1	O	O
;	O	O
yielding	O	O
36	O	O
con	O	O
transverse	O	O
functional	O	O
images	O	O
in	O	O
an	O	O
80	O	O
×	O	O
80	O	O
matrix	O	O
with	O	O
an	O	O
is	O	O
resolution	O	O
of	O	O
3	O	O
mm	O	O
]	O	O
.	O	O
T	B-T1WeightedImaging	B-E
-	I-T1WeightedImaging	I-E
weighted	I-T1WeightedImaging	I-E
an	O	B-E
reference	O	I-E
images	O	I-E
were	O	O
acquired	O	O
in	O	O
the	O	O
same	O	O
planes	O	O
and	O	O
thickness	O	O
immediately	O	O
following	O	O
the	O	O
resting	O	O
scan	O	O
.	O	O
f	B-FunctionalMagneticResonanceImaging	B-E
data	I-FunctionalMagneticResonanceImaging	O
analysis	I-FunctionalMagneticResonanceImaging	O
Rest	B-RestingStateImaging	B-E
state	I-RestingStateImaging	O
data	I-RestingStateImaging	O
were	O	O
analyzed	O	O
using	O	O
a	O	O
seed	O	O
driven	O	O
approach	O	O
(	O	O
http	O	O
:	O	O
/	O	O
/	O	O
www	O	O
/	O	O
projects	O	O
/	O	O
con	O	O
)	O	O
.	O	O
We	O	O
used	O	O
methods	O	O
that	O	O
minimize	O	O
the	O	O
influence	O	O
of	O	O
motion	O	O
and	O	O
artifact	O	O
and	O	O
that	O	O
allow	O	O
for	O	O
valid	O	O
identification	O	O
of	O	O
correlated	O	O
and	O	O
anti	O	O
networks	O	O
.	O	O
Data	O	O
were	O	O
slice	O	O
time	O	O
corrected	O	O
,	O	O
real	O	O
,	O	O
core	O	O
,	O	O
normal	O	O
,	O	O
and	O	O
spatial	O	O
smoothed	O	O
with	O	O
a	O	O
6	O	O
-	O	O
mm	O	O
kernel	O	O
.	O	O
To	O	O
address	O	O
the	O	O
spur	O	O
correlation	O	O
in	O	O
resting	O	O
networks	O	O
caused	O	O
by	O	O
head	O	O
motion	O	O
we	O	O
used	O	O
quality	O	O
assurance	O	O
software	O	O
Art	O	O
Det	O	O
Too	O	O
(	O	O
http	O	O
:	O	O
/	O	O
/	O	O
www	O	O
/	O	O
projects	O	O
/	O	O
artifact	O	O
;	O	O
http	O	O
:	O	O
/	O	O
/	O	O
www	O	O
/	O	O
projects	O	O
/	O	O
con	O	O
)	O	O
to	O	O
identify	O	O
problematic	O	O
time	O	O
points	O	O
during	O	O
the	O	O
scan	O	O
.	O	O
Specifically	O	O
,	O	O
an	O	O
image	O	O
was	O	O
defined	O	O
as	O	O
an	O	O
out	O	O
if	O	O
the	O	O
head	O	O
displacement	O	O
in	O	O
x	O	O
,	O	O
y	O	O
,	O	O
or	O	O
z	O	O
direction	O	O
was	O	O
greater	O	O
than	O	O
.	O	O
from	O	O
the	O	O
previous	O	O
frame	O	O
,	O	O
or	O	O
if	O	O
the	O	O
global	O	O
mean	O	O
intensity	O	O
in	O	O
the	O	O
image	O	O
was	O	O
greater	O	O
than	O	O
3	O	O
standard	O	O
de	O	O
from	O	O
the	O	O
mean	O	O
image	O	O
intensity	O	O
for	O	O
the	O	O
entire	O	O
resting	O	O
scan	O	O
.	O	O
A	O	O
single	O	O
re	O	O
for	O	O
each	O	O
out	O	O
image	O	O
was	O	O
included	O	O
in	O	O
the	O	O
first	O	O
level	O	O
general	O	O
linear	O	O
model	O	O
along	O	O
with	O	O
motion	O	O
parameters	O	O
and	O	O
first	O	O
order	O	O
derivatives	O	O
.	O	O
Ph	O	O
and	O	O
other	O	O
spur	O	O
sources	O	O
of	O	O
noise	O	O
were	O	O
estimated	O	O
and	O	O
re	O	O
using	O	O
the	O	O
an	O	O
Co	O	O
method	O	O
(	O	O
a	O	O
)	O	O
as	O	O
opposed	O	O
to	O	O
global	O	O
signal	O	O
re	O	O
,	O	O
a	O	O
widely	O	O
used	O	O
pre	O	O
method	O	O
known	O	O
to	O	O
artificial	O	O
introduce	O	O
negative	O	O
correlation	O	O
.	O	O
The	O	O
an	B-StructuralImaging	O
image	I-StructuralImaging	O
for	O	O
each	O	O
participant	O	O
was	O	O
segment	O	O
into	O	O
white	O	O
matter	O	O
,	O	O
grey	O	O
matter	O	O
,	O	O
and	O	O
c	O	O
fluid	O	O
(	O	O
CS	O	O
)	O	O
masks	O	O
using	O	O
SP	O	O
.	O	O
To	O	O
minimize	O	O
partial	O	O
vol	O	O
with	O	O
grey	O	O
matter	O	O
,	O	O
the	O	O
white	O	O
matter	O	O
and	O	O
CS	O	O
masks	O	O
were	O	O
eroded	O	O
by	O	O
one	O	O
v	O	O
,	O	O
which	O	O
resulted	O	O
in	O	O
substantially	O	O
smaller	O	O
masks	O	O
than	O	O
the	O	O
original	O	O
segment	O	O
.	O	O
The	O	O
eroded	O	O
white	O	O
matter	O	O
and	O	O
CS	O	O
masks	O	O
were	O	O
then	O	O
used	O	O
as	O	O
noise	O	O
regions	O	O
of	O	O
interest	O	O
(	O	O
R	O	O
)	O	O
.	O	O
Signal	O	O
from	O	O
the	O	O
white	O	O
matter	O	O
and	O	O
CS	O	O
noise	O	O
R	O	O
were	O	O
extracted	O	O
from	O	O
the	O	O
un	O	O
functional	O	O
volumes	O	O
to	O	O
avoid	O	O
additional	O	O
risk	O	O
of	O	O
con	O	O
white	O	O
matter	O	O
and	O	O
CS	O	O
signals	O	O
with	O	O
grey	O	O
matter	O	O
signals	O	O
.	O	O
Previous	O	O
results	O	O
showed	O	O
that	O	O
a	O	O
signals	O	O
were	O	O
considerably	O	O
different	O	O
from	O	O
the	O	O
global	O	O
signal	O	O
,	O	O
as	O	O
re	O	O
higher	O	O
order	O	O
principal	O	O
components	O	O
of	O	O
the	O	O
global	O	O
signal	O	O
diminished	O	O
both	O	O
positive	O	O
and	O	O
negative	O	O
correlation	O	O
whereas	O	O
re	O	O
a	O	O
signals	O	O
resulted	O	O
in	O	O
stronger	O	O
anti	O	O
and	O	O
eliminated	O	O
spur	O	O
correlation	O	O
.	O	O
Based	O	O
on	O	O
previous	O	O
results	O	O
,	O	O
five	O	O
principal	O	O
components	O	O
of	O	O
the	O	O
signals	O	O
from	O	O
white	O	O
matter	O	O
and	O	O
CS	O	O
noise	O	O
R	O	O
were	O	O
removed	O	O
with	O	O
re	O	O
.	O	O
A	O	O
temporal	O	O
band	O	O
filter	O	O
of	O	O
0	O	O
Hz	O	O
to	O	O
0	O	O
Hz	O	O
was	O	O
applied	O	O
to	O	O
the	O	O
time	O	O
series	O	O
.	O	O
The	O	O
residual	O	O
B	O	O
time	O	O
was	O	O
band	O	O
filtered	O	O
over	O	O
a	O	O
low	O	O
window	O	O
of	O	O
interest	O	O
(	O	O
0	O	O
<	O	O
f	O	O
<	O	O
0	O	O
)	O	O
.	O	O
Co	O	O
maps	O	O
were	O	O
produced	O	O
by	O	O
extract	O	O
the	O	O
residual	O	O
B	O	O
time	O	O
course	O	O
from	O	O
seed	O	O
regions	O	O
based	O	O
on	O	O
the	O	O
literature	O	O
.	O	O
The	O	O
D	O	O
seed	O	O
was	O	O
defined	O	O
using	O	O
a	O	O
10	O	O
mm	O	O
sphere	O	O
around	O	O
peak	O	O
MP	O	O
coordinates	O	O
,	O	O
as	O	O
specified	O	O
in	O	O
.	O	O
Pearson	O	O
’	O	O
s	O	O
correlation	O	O
coefficients	O	O
were	O	O
then	O	O
calculated	O	O
between	O	O
the	O	O
D	O	O
time	O	O
course	O	O
and	O	O
the	O	O
time	O	O
course	O	O
of	O	O
all	O	O
other	O	O
v	O	O
in	O	O
the	O	O
brain	O	O
.	O	O
Co	O	O
coefficients	O	O
were	O	O
converted	O	O
to	O	O
normally	O	O
distributed	O	O
scores	O	O
using	O	O
Fisher	O	O
’	O	O
s	O	O
transformation	O	O
to	O	O
allow	O	O
for	O	O
second	O	O
General	O	O
Line	O	O
Model	O	O
analyses	O	O
.	O	O
Second	O	O
within	O	O
(	O	O
one	O	O
sample	O	O
t	O	O
)	O	O
and	O	O
between	O	O
group	O	O
(	O	O
AN	O	O
)	O	O
analyses	O	O
were	O	O
performed	O	O
on	O	O
the	O	O
Z	O	O
from	O	O
the	O	O
MP	O	O
.	O	O
Co	O	O
for	O	O
multiple	O	O
comparisons	O	O
on	O	O
analyses	O	O
were	O	O
implemented	O	O
with	O	O
an	O	O
F	O	O
correction	O	O
of	O	O
p	O	O
<	O	O
0	O	O
.	O	O
Red	O	O
Pa	O	O
Alpha	O	O
Power	O	O
and	O	O
P	O	O
S	O	O
:	O	O
Test	O	O
Re	O	O
of	O	O
Rest	O	B-E
Ma	O	O
in	O	O
Sc	O	B-E
and	O	O
Health	O	B-E
Control	O	I-E
Background	O	O
:	O	O
Despite	O	O
increased	O	O
reporting	O	O
of	O	O
resting	O	B-E
magnet	O	O
(	O	I-E
ME	O	I-E
)	O	O
,	O	O
reliability	O	O
of	O	O
those	O	O
measures	O	O
remains	O	O
scarce	O	O
and	O	O
pre	O	O
reported	O	O
in	O	O
healthy	B-NoKnownDisorder	B-E
controls	I-NoKnownDisorder	I-E
(	O	O
HC	O	I-E
)	O	I-E
.	O	O
As	O	O
such	O	O
,	O	O
there	O	O
is	O	O
limited	O	O
knowledge	O	O
on	O	O
ME	O	O
resting	O	O
reliability	O	O
in	O	O
s	B-Schizophrenia	O
(	O	O
S	O	I-E
)	O	O
.	O	O
Method	O	O
:	O	O
To	O	O
address	O	O
test	O	O
reliability	O	O
in	O	O
ps	O	O
,	O	O
a	O	O
re	O	O
study	O	O
of	O	O
26	O	O
participants	O	O
(	O	O
13	O	O
-	O	O
S	O	O
,	O	O
13	O	O
-	O	O
HC	O	O
)	O	O
was	O	O
performed	O	O
.	O	O
We	O	O
collected	O	O
eyes	O	O
open	O	O
and	O	O
eyes	O	O
closed	O	O
resting	B-RestingStateImaging	O
data	I-RestingStateImaging	O
during	O	O
4	O	O
separate	O	O
instances	O	O
(	O	O
2	O	O
V	O	O
,	O	O
2	O	O
runs	O	O
per	O	O
visit	O	O
)	O	O
to	O	O
estimate	O	O
spectral	O	O
power	O	O
reliability	O	O
(	O	O
power	O	O
,	O	O
normal	O	O
power	O	O
,	O	O
alpha	O	O
react	O	O
)	O	O
across	O	O
one	O	O
hour	O	O
and	O	O
one	O	O
week	O	O
.	O	O
In	O	O
correlation	O	O
coefficients	O	O
(	O	O
ICC	O	O
)	O	O
were	O	O
calculated	O	O
.	O	O
For	O	O
source	O	O
modeling	O	O
,	O	O
we	O	O
applied	O	O
an	O	O
an	O	O
con	O	O
linear	O	O
est	O	O
inverse	O	O
model	O	O
known	O	O
as	O	O
dynamic	O	O
statistical	O	O
para	O	O
mapping	O	O
(	O	O
M	O	O
d	O	O
)	O	O
and	O	O
source	O	O
connectivity	O	O
using	O	O
the	O	O
weighted	O	O
phase	O	O
la	O	O
index	O	O
.	O	O
Results	O	O
:	O	O
Across	O	O
one	O	O
week	O	O
there	O	O
was	O	O
excellent	O	O
test	O	O
reliability	O	O
in	O	O
global	O	O
spectral	O	O
measures	O	O
in	O	O
the	O	O
bands	O	O
(	O	O
HC	O	O
ICC	O	O
=	O	O
0	O	O
,	O	O
S	O	O
ICC	O	O
=	O	O
0	O	O
)	O	O
,	O	O
regional	O	O
spectral	O	O
measures	O	O
in	O	O
all	O	O
bands	O	O
(	O	O
HC	O	O
ICC	O	O
=	O	O
0	O	O
,	O	O
S	O	O
ICC	O	O
=	O	O
0	O	O
)	O	O
,	O	O
and	O	O
par	O	O
alpha	O	O
measures	O	O
(	O	O
HC	O	O
ICC	O	O
=	O	O
0	O	O
,	O	O
S	O	O
ICC	O	O
=	O	O
0	O	O
)	O	O
.	O	O
Conversely	O	O
,	O	O
functional	O	O
connectivity	O	O
had	O	O
poor	O	O
reliability	O	O
,	O	O
as	O	O
did	O	O
source	O	O
spectral	O	O
power	O	O
across	O	O
one	O	O
hour	O	O
for	O	O
S	B-Schizophrenia	O
.	O	O
Re	O	O
to	O	O
HC	B-NoKnownDisorder	O
,	O	O
S	B-Schizophrenia	O
also	O	O
had	O	O
reduced	O	O
par	O	O
alpha	O	O
normal	O	O
power	O	O
during	O	O
eyes	O	O
closed	O	O
only	O	O
,	O	O
reduced	O	O
alpha	O	O
react	O	O
,	O	O
and	O	O
an	O	O
association	O	O
between	O	O
higher	O	O
PA	O	O
positive	O	O
scores	O	O
and	O	O
lower	O	O
par	O	O
alpha	O	O
power	O	O
.	O	O
Con	O	O
:	O	O
There	O	O
was	O	O
excellent	O	O
to	O	O
good	O	O
test	O	O
reliability	O	O
in	O	O
most	O	O
ME	B-Magnetoencephalography	O
spectral	O	O
measures	O	O
with	O	O
a	O	O
few	O	O
exceptions	O	O
in	O	O
the	O	O
s	B-Schizophrenia	O
patient	O	O
group	O	O
.	O	O
Overall	O	O
,	O	O
these	O	O
findings	O	O
encourage	O	O
the	O	O
use	O	O
of	O	O
resting	O	B-E
ME	O	O
while	O	O
emphasizing	O	O
the	O	O
importance	O	O
of	O	O
determining	O	O
reliability	O	O
in	O	O
clinical	O	O
populations	O	O
.	O	O
Materials	B-StudyMethod	B-E
and	I-StudyMethod	I-E
Method	I-StudyMethod	I-E
Part	O	I-E
The	O	O
current	O	O
study	O	O
included	O	O
13	O	O
individuals	O	O
diagnosed	O	I-E
with	O	I-E
s	B-Schizophrenia	I-E
(	I-Schizophrenia	I-E
S	I-Schizophrenia	I-E
)	I-Schizophrenia	I-E
and	O	O
13	O	O
healthy	B-NoKnownDisorder	B-E
controls	I-NoKnownDisorder	I-E
(	I-NoKnownDisorder	I-E
HC	I-NoKnownDisorder	I-E
)	I-NoKnownDisorder	I-E
,	O	O
age	O	O
and	O	O
gender	O	O
matched	O	O
,	O	O
Table	O	O
1	O	O
.	O	O
In	O	O
consent	O	O
was	O	O
obtained	O	O
from	O	O
all	O	O
participants	O	O
according	O	O
to	O	O
institutional	O	O
guidelines	O	O
.	O	O
The	O	O
study	O	O
was	O	O
approved	O	O
by	O	O
the	O	O
University	O	O
of	O	O
New	O	O
Mexico	O	O
Health	O	O
Sciences	O	O
Center	O	O
Human	O	O
Research	O	O
Review	O	O
Committee	O	O
.	O	O
All	O	O
participants	O	O
were	O	O
within	O	O
21	O	O
–	O	O
49	O	O
years	O	O
of	O	O
age	O	O
with	O	O
no	O	O
history	O	O
of	O	O
ne	O	O
disorder	O	O
(	O	O
e	O	O
.	O	O
e	O	O
)	O	O
,	O	O
no	O	O
history	O	O
of	O	O
major	O	O
head	O	O
trauma	O	O
(	O	O
loss	O	O
of	O	O
consciousness	O	O
>	O	O
5	O	O
min	O	O
)	O	O
,	O	O
no	O	O
current	O	O
substance	O	O
abuse	O	I-E
diagnosis	O	I-E
(	O	O
excluding	O	O
ni	O	O
)	O	O
,	O	O
no	O	O
current	O	O
dependence	O	O
/	O	O
abuse	O	O
of	O	O
PC	O	O
/	O	O
am	O	O
/	O	O
cocaine	O	O
within	O	O
the	O	O
past	O	O
12	O	O
months	O	O
,	O	O
and	O	O
were	O	O
not	O	O
currently	O	O
on	O	O
mood	O	O
stab	O	O
such	O	O
as	O	O
lit	O	O
or	O	O
v	O	O
acid	O	O
.	O	O
HC	B-NoKnownDisorder	O
had	O	O
I	O	O
scores	O	O
within	O	O
the	O	O
normal	O	O
range	O	O
and	O	O
no	O	O
history	O	O
of	O	O
developmental	O	O
delays	O	O
or	O	O
ne	O	O
or	O	O
psychiatric	O	O
disorders	O	O
based	O	O
on	O	O
the	O	O
Structure	B-MentalHealthDiagnosisScale	B-E
Clinical	I-MentalHealthDiagnosisScale	I-E
Interview	I-MentalHealthDiagnosisScale	I-E
for	I-MentalHealthDiagnosisScale	I-E
DS	I-MentalHealthDiagnosisScale	I-E
(	I-MentalHealthDiagnosisScale	I-E
SC	I-MentalHealthDiagnosisScale	I-E
)	I-MentalHealthDiagnosisScale	I-E
.	O	O
HC	O	O
also	O	O
did	O	O
not	O	O
have	O	O
a	O	O
family	O	O
history	O	O
of	O	O
a	O	O
ps	O	O
disorder	O	O
in	O	O
first	O	O
relatives	O	O
or	O	O
a	O	O
history	O	O
of	O	O
more	O	O
than	O	O
1	O	O
lifetime	O	O
de	O	O
episode	O	O
.	O	O
Part	B-Schizophrenia	O
with	I-Schizophrenia	I-E
s	I-Schizophrenia	I-E
were	O	O
confirmed	O	O
to	O	O
have	O	O
a	O	O
DS	O	I-E
diagnosis	O	I-E
of	O	I-E
s	B-Schizophrenia	I-E
with	O	O
the	O	O
Structure	B-MentalHealthDiagnosisScale	B-E
Clinical	I-MentalHealthDiagnosisScale	I-E
Interview	I-MentalHealthDiagnosisScale	I-E
for	I-MentalHealthDiagnosisScale	I-E
DS	I-MentalHealthDiagnosisScale	I-E
(	I-MentalHealthDiagnosisScale	I-E
SC	I-MentalHealthDiagnosisScale	I-E
)	I-MentalHealthDiagnosisScale	I-E
and	O	O
retrospective	O	O
clinical	O	O
stability	O	O
.	O	O
Part	O	O
were	O	O
not	O	O
excluded	O	O
for	O	O
ni	O	O
use	O	O
,	O	O
however	O	O
,	O	O
they	O	O
were	O	O
not	O	O
allowed	O	O
to	O	O
smoke	O	O
within	O	O
1	O	O
hour	O	O
of	O	O
the	O	O
ME	O	O
session	O	O
or	O	O
be	O	O
more	O	O
than	O	O
5	O	O
hours	O	O
from	O	O
their	O	O
previous	O	O
cigarette	O	O
to	O	O
avoid	O	O
con	O	O
of	O	O
acute	O	O
ni	O	O
exposure	O	O
or	O	O
withdrawal	O	O
.	O	O
The	O	O
following	O	O
assessments	O	O
were	O	O
collected	O	O
in	O	O
S	B-Schizophrenia	B-E
participants	O	O
and	O	O
reported	O	O
in	O	O
Table	O	O
1	O	O
:	O	O
We	B-NeurocognitiveTest	B-E
Test	I-NeurocognitiveTest	I-E
of	I-NeurocognitiveTest	I-E
Adult	I-NeurocognitiveTest	I-E
Reading	I-NeurocognitiveTest	I-E
(	I-NeurocognitiveTest	I-E
WTA	I-NeurocognitiveTest	I-E
)	I-NeurocognitiveTest	I-E
,	I-NeurocognitiveTest	I-E
Standard	I-NeurocognitiveTest	I-E
and	I-NeurocognitiveTest	I-E
Pre	I-NeurocognitiveTest	I-E
(	I-NeurocognitiveTest	I-E
pre	I-NeurocognitiveTest	I-E
)	I-NeurocognitiveTest	I-E
I	I-NeurocognitiveTest	I-E
,	O	I-E
Po	B-PositiveandNegativeSyndromeScale	I-E
and	I-PositiveandNegativeSyndromeScale	I-E
N	I-PositiveandNegativeSyndromeScale	I-E
S	I-PositiveandNegativeSyndromeScale	I-E
Scale	I-PositiveandNegativeSyndromeScale	I-E
(	I-PositiveandNegativeSyndromeScale	I-E
PA	I-PositiveandNegativeSyndromeScale	I-E
)	I-PositiveandNegativeSyndromeScale	I-E
,	O	O
anti	O	B-E
medication	O	I-E
dose	O	O
information	O	O
,	O	O
and	O	O
duration	O	O
of	O	O
illness	O	O
.	O	O
PA	B-PositiveandNegativeSyndromeScale	O
scores	O	O
were	O	O
determined	O	O
for	O	O
each	O	O
visit	O	O
.	O	O
Anti	O	O
medication	O	O
was	O	O
converted	O	O
to	O	O
o	O	O
equivalent	O	O
for	O	O
comparison	O	O
between	O	O
medication	O	O
.	O	O
Du	O	O
of	O	O
illness	O	O
was	O	O
calculated	O	O
by	O	O
sub	O	O
age	O	O
at	O	O
onset	O	O
of	O	O
ps	O	O
symptoms	O	O
from	O	O
current	O	O
age	O	O
.	O	O
ME	O	O
Be	O	O
Task	O	O
All	O	O
participants	O	O
had	O	O
two	O	O
visits	O	O
across	O	O
7	O	O
days	O	O
[	O	O
HC	O	O
=	O	O
7	O	O
days	O	O
±	O	O
60	O	O
minutes	O	O
,	O	O
S	O	O
=	O	O
7	O	O
days	O	O
±	O	O
51	O	O
minutes	O	O
]	O	O
.	O	O
Time	O	O
of	O	O
day	O	O
between	O	O
visits	O	O
was	O	O
matched	O	O
to	O	O
take	O	O
into	O	O
account	O	O
circa	O	O
rhythm	O	O
.	O	O
Each	O	O
visit	O	O
began	O	O
with	O	O
a	O	O
10	O	O
-	O	O
minute	O	O
rest	B-RestingStateImaging	O
task	I-RestingStateImaging	O
(	O	O
referred	O	O
to	O	O
as	O	O
Rest	O	O
)	O	O
and	O	O
ended	O	O
with	O	O
a	O	O
4	O	O
-	O	O
minute	O	O
rest	B-RestingStateImaging	O
task	I-RestingStateImaging	O
(	O	O
referred	O	O
to	O	O
as	O	O
Rest	O	O
)	O	O
,	O	O
see	O	O
Figure	O	O
1	O	O
.	O	O
No	O	O
responses	O	O
were	O	O
required	O	O
from	O	O
the	O	O
participant	O	O
;	O	O
however	O	O
,	O	O
participants	O	O
were	O	O
instructed	O	O
to	O	O
attend	O	O
the	O	O
instructions	O	O
for	O	O
pro	O	O
to	O	O
close	O	O
their	O	O
eyes	O	O
or	O	O
fix	O	O
on	O	O
a	O	O
white	O	O
cross	O	O
.	O	O
Each	O	O
task	O	O
alternate	O	O
between	O	O
EC	O	O
and	O	O
E	O	O
.	O	O
In	O	O
total	O	O
,	O	O
resting	B-RestingStateImaging	B-E
activity	I-RestingStateImaging	O
was	O	O
recorded	O	O
4	O	O
separate	O	O
times	O	O
with	O	O
14	O	O
minutes	O	O
of	O	O
E	O	O
and	O	O
14	O	O
minutes	O	O
of	O	O
EC	O	O
.	O	O
ME	O	O
Data	O	O
A	O	O
ME	B-Magnetoencephalography	O
data	O	O
were	O	O
collected	O	O
in	O	O
a	O	O
magnetic	O	O
shield	O	O
room	O	O
(	O	O
V	O	O
–	O	O
A	O	O
)	O	O
at	O	O
the	O	O
Mind	O	O
Research	O	O
Network	O	O
in	O	O
Albuquerque	O	O
,	O	O
New	O	O
Mexico	O	O
using	O	O
a	O	O
306	O	O
-	O	O
channel	O	O
whole	O	O
ME	B-Magnetoencephalography	O
system	O	O
(	O	O
El	O	O
N	O	O
)	O	O
with	O	O
a	O	O
sampling	O	O
rate	O	O
of	O	O
1000	O	O
Hz	O	O
and	O	O
an	O	O
anti	O	O
filter	O	O
with	O	O
a	O	O
pass	O	O
of	O	O
0	O	O
–	O	O
330	O	O
Hz	O	O
.	O	O
Prior	O	O
to	O	O
data	O	O
acquisition	O	O
,	O	O
four	O	O
electromagnetic	O	O
coil	O	O
were	O	O
placed	O	O
on	O	O
the	O	O
participant	O	O
’	O	O
s	O	O
mast	O	O
bone	O	O
and	O	O
upper	O	O
forehead	O	O
,	O	O
along	O	O
with	O	O
electro	O	O
and	O	O
electro	O	O
channels	O	O
.	O	O
The	O	O
location	O	O
of	O	O
the	O	O
coil	O	O
were	O	O
registered	O	O
to	O	O
the	O	O
na	O	O
and	O	O
pre	O	O
points	O	O
using	O	O
three	O	O
digit	O	O
equipment	O	O
(	O	O
Pol	O	O
Fast	O	O
)	O	O
.	O	O
Part	O	O
sat	O	O
upright	O	O
in	O	O
the	O	O
ME	B-Magnetoencephalography	O
during	O	O
the	O	O
task	O	O
.	O	O
Con	O	O
Head	O	O
Po	O	O
In	O	O
(	O	O
c	O	O
)	O	O
monitoring	O	O
allowed	O	O
for	O	O
motion	O	O
correction	O	O
.	O	O
Head	O	O
position	O	O
was	O	O
checked	O	O
between	O	O
visits	O	O
.	O	O
For	O	O
the	O	O
Rest	B-RestingStateImaging	O
task	I-RestingStateImaging	O
,	O	O
average	O	O
E	O	O
distance	O	O
between	O	O
visits	O	O
was	O	O
4	O	O
mm	O	O
for	O	O
HC	B-NoKnownDisorder	O
and	O	O
6	O	O
mm	O	O
for	O	O
S	B-Schizophrenia	O
.	O	O
For	O	O
the	O	O
Rest	B-RestingStateImaging	O
task	I-RestingStateImaging	O
,	O	O
the	O	O
distance	O	O
was	O	O
4	O	O
mm	O	O
for	O	O
HC	B-NoKnownDisorder	O
and	O	O
6	O	O
mm	O	O
for	O	O
S	B-Schizophrenia	O
.	O	O
Head	O	O
position	O	O
consistency	O	O
was	O	O
similar	O	O
between	O	O
HC	B-NoKnownDisorder	O
and	O	O
S	B-Schizophrenia	O
(	O	O
all	O	O
p	O	O
’	O	O
s	O	O
>	O	O
0	O	O
)	O	O
.	O	O
St	O	O
MR	O	I-E
Data	O	O
A	O	O
St	B-StructuralImaging	O
MR	I-StructuralImaging	O
were	O	O
obtained	O	O
for	O	O
mapping	O	O
source	O	O
locations	O	O
.	O	O
Sa	O	B-E
T	B-T1WeightedImaging	B-E
-	I-T1WeightedImaging	I-E
weighted	I-T1WeightedImaging	I-E
an	B-StructuralImaging	I-E
MR	I-StructuralImaging	I-E
images	I-StructuralImaging	I-E
were	O	O
obtained	O	O
using	O	O
a	O	O
Siemens	O	O
T	O	O
Trio	O	O
3	O	O
Te	O	O
MR	O	O
system	O	O
with	O	O
a	O	O
32	O	O
-	O	O
channel	O	O
head	O	O
coil	O	O
.	O	O
Para	O	O
of	O	O
the	O	O
multi	O	O
3D	O	O
MP	B-T1WeightedImaging	O
sequence	I-T1WeightedImaging	O
were	O	O
:	O	O
T	O	O
/	O	O
T	O	O
/	O	O
T	O	O
=	O	O
253	O	O
/	O	O
1	O	O
,	O	O
3	O	O
,	O	O
5	O	O
,	O	O
7	O	O
,	O	O
9	O	O
/	O	O
1200	O	O
m	O	O
,	O	O
flip	O	O
angle	O	O
=	O	O
7	O	O
°	O	O
,	O	O
field	O	O
of	O	O
view	O	O
(	O	O
F	O	O
)	O	O
=	O	O
256	O	O
mm	O	O
x	O	O
256	O	O
mm	O	O
,	O	O
matrix	O	O
=	O	O
256	O	O
×	O	O
256	O	O
,	O	O
1	O	O
mm	O	O
thick	O	O
slice	O	O
,	O	O
192	O	O
slice	O	O
,	O	O
G	O	O
acceleration	O	O
=	O	O
2	O	O
.	O	O
ME	O	O
Data	O	O
Pre	O	O
Raw	O	O
ME	B-Magnetoencephalography	O
data	O	O
were	O	O
filtered	O	O
for	O	O
noise	O	O
and	O	O
corrected	O	O
for	O	O
head	O	O
motion	O	O
with	O	O
the	O	O
N	O	O
Max	O	O
2	O	O
software	O	O
using	O	O
the	O	O
temporal	O	O
extension	O	O
of	O	O
signal	O	O
space	O	O
separation	O	O
(	O	O
t	O	O
)	O	O
method	O	O
with	O	O
movement	O	O
compensation	O	O
.	O	O
ME	B-Magnetoencephalography	O
data	O	O
from	O	O
each	O	O
subject	O	O
’	O	O
s	O	O
V	O	O
2	O	O
was	O	O
transformed	O	O
to	O	O
V	O	O
1	O	O
head	O	O
position	O	O
using	O	O
Max	O	O
2	O	O
Max	O	O
option	O	O
to	O	O
ensure	O	O
equivalent	O	O
sensor	O	O
locations	O	O
between	O	O
visits	O	O
.	O	O
No	O	O
down	O	O
of	O	O
the	O	O
data	O	O
was	O	O
implemented	O	O
at	O	O
the	O	O
pre	O	O
stage	O	O
.	O	O
Heart	O	O
and	O	O
eye	O	O
artifacts	O	O
were	O	O
automatically	O	O
detected	O	O
and	O	O
removed	O	O
using	O	O
signal	O	O
space	O	O
projection	O	O
(	O	O
SS	O	O
)	O	O
in	O	O
M	O	O
software	O	O
.	O	O
The	O	O
continuous	O	O
data	O	O
were	O	O
segment	O	O
into	O	O
artifact	O	O
2	O	O
second	O	O
e	O	O
.	O	O
E	O	O
in	O	O
which	O	O
the	O	O
magnetic	O	O
field	O	O
exceeded	O	O
5	O	O
p	O	O
were	O	O
rejected	O	O
.	O	O
HC	B-NoKnownDisorder	O
had	O	O
2	O	O
and	O	O
S	B-Schizophrenia	O
had	O	O
4	O	O
of	O	O
all	O	O
e	O	O
rejected	O	O
.	O	O
The	O	O
total	O	O
number	O	O
of	O	O
e	O	O
used	O	O
for	O	O
further	O	O
analysis	O	O
included	O	O
401	O	O
EC	O	O
,	O	O
40	O	O
E	O	O
e	O	O
in	O	O
HC	B-NoKnownDisorder	O
,	O	O
and	O	O
39	O	O
EC	O	O
,	O	O
40	O	O
E	O	O
e	O	O
in	O	O
S	B-Schizophrenia	O
.	O	O
The	O	O
number	O	O
of	O	O
closed	O	O
/	O	O
open	O	O
e	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
groups	O	O
(	O	O
all	O	O
p	O	O
’	O	O
s	O	O
>	O	O
0	O	O
)	O	O
.	O	O
ME	O	O
S	O	O
Ana	O	O
For	O	O
sensor	O	O
analysis	O	O
,	O	O
we	O	O
applied	O	O
the	O	O
summary	O	O
spectral	O	O
measures	O	O
described	O	O
in	O	O
to	O	O
si	O	O
multi	O	O
ME	B-Magnetoencephalography	O
spectral	O	O
data	O	O
.	O	O
Using	O	O
only	O	O
plan	O	O
g	O	O
,	O	O
the	O	O
sensor	O	O
array	O	O
was	O	O
divided	O	O
into	O	O
left	O	O
and	O	O
right	O	O
equivalent	O	O
regions	O	O
,	O	O
see	O	O
Figure	O	O
2	O	O
.	O	O
S	O	O
power	O	O
was	O	O
estimated	O	O
using	O	O
Mat	O	O
’	O	O
s	O	O
FF	O	O
function	O	O
with	O	O
a	O	O
window	O	O
size	O	O
of	O	O
204	O	O
for	O	O
the	O	O
following	O	O
frequency	O	O
bands	O	O
:	O	O
Delta	O	O
(	O	O
1	O	O
–	O	O
4	O	O
Hz	O	O
)	O	O
,	O	O
The	O	O
(	O	O
5	O	O
–	O	O
8	O	O
Hz	O	O
)	O	O
,	O	O
Alpha	O	O
(	O	O
9	O	O
–	O	O
13	O	O
Hz	O	O
)	O	O
,	O	O
Beta	O	O
(	O	O
14	O	O
–	O	O
29	O	O
Hz	O	O
)	O	O
,	O	O
and	O	O
Gamma	O	O
(	O	O
31	O	O
–	O	O
58	O	O
Hz	O	O
)	O	O
.	O	O
S	O	O
measures	O	O
included	O	O
:	O	O
power	O	O
,	O	O
normal	O	O
power	O	O
,	O	O
half	O	O
,	O	O
Shannon	O	O
S	O	O
En	O	O
(	O	O
SS	O	O
)	O	O
,	O	O
and	O	O
alpha	O	O
react	O	O
.	O	O
Normal	O	O
power	O	O
was	O	O
obtained	O	O
by	O	O
dividing	O	O
the	O	O
power	O	O
within	O	O
the	O	O
frequency	O	O
band	O	O
by	O	O
total	O	O
1	O	O
–	O	O
50	O	O
Hz	O	O
power	O	O
.	O	O
Half	O	O
power	O	O
was	O	O
defined	O	O
as	O	O
the	O	O
mid	O	O
frequency	O	O
where	O	O
half	O	O
of	O	O
the	O	O
power	O	O
is	O	O
below	O	O
/	O	O
above	O	O
for	O	O
the	O	O
1	O	O
–	O	O
50	O	O
Hz	O	O
range	O	O
and	O	O
indicates	O	O
overall	O	O
spectral	O	O
power	O	O
shifts	O	O
from	O	O
low	O	O
to	O	O
high	O	O
frequencies	O	O
.	O	O
Alpha	O	O
react	O	O
was	O	O
calculated	O	O
using	O	O
normal	O	O
spectral	O	O
power	O	O
values	O	O
with	O	O
the	O	O
following	O	O
:	O	O
(	O	O
EC	O	O
)	O	O
/	O	O
E	O	O
.	O	O
Global	O	O
measures	O	O
were	O	O
the	O	O
average	O	O
of	O	O
all	O	O
regions	O	O
and	O	O
g	O	O
.	O	O
For	O	O
source	O	O
analysis	O	O
,	O	O
the	O	O
co	O	O
surface	O	O
of	O	O
each	O	O
participant	O	O
was	O	O
reconstructed	O	O
from	O	O
T	B-T1WeightedImaging	B-E
-	I-T1WeightedImaging	I-E
weighted	I-T1WeightedImaging	I-E
MR	O	I-E
files	O	I-E
using	O	O
Free	O	O
with	O	O
a	O	O
repeatedly	O	O
subdivided	O	O
o	O	O
as	O	O
the	O	O
spatial	O	O
sub	O	O
method	O	O
,	O	O
creating	O	O
4	O	O
locations	O	O
per	O	O
hemisphere	O	O
with	O	O
a	O	O
source	O	O
space	O	O
of	O	O
4	O	O
mm	O	O
.	O	O
Source	O	O
analysis	O	O
was	O	O
performed	O	O
with	O	O
M	O	O
software	O	O
using	O	O
an	O	O
an	O	O
con	O	O
linear	O	O
est	O	O
inverse	O	O
model	O	O
known	O	O
as	O	O
dynamic	O	O
statistical	O	O
para	O	O
mapping	O	O
(	O	O
d	O	O
)	O	O
.	O	O
The	O	O
regular	O	O
parameter	O	O
correspond	O	O
with	O	O
a	O	O
signal	O	O
ratio	O	O
of	O	O
3	O	O
.	O	O
Source	O	O
orientation	O	O
had	O	O
a	O	O
loose	O	O
con	O	O
of	O	O
0	O	O
.	O	O
The	O	O
forward	O	O
solution	O	O
was	O	O
calculated	O	O
with	O	O
a	O	O
single	O	O
layer	O	O
(	O	O
inner	O	O
skull	O	O
)	O	O
boundary	O	O
element	O	O
method	O	O
.	O	O
The	O	O
d	O	O
inverse	O	O
model	O	O
identified	O	O
where	O	O
the	O	O
estimated	O	O
current	O	O
at	O	O
each	O	O
co	O	O
surface	O	O
vertex	O	O
differed	O	O
significantly	O	O
from	O	O
base	O	O
noise	O	O
(	O	O
empty	O	O
room	O	O
data	O	O
)	O	O
.	O	O
Power	O	O
spectral	O	O
density	O	O
(	O	O
PS	O	O
)	O	O
measures	O	O
were	O	O
com	O	O
from	O	O
e	O	O
using	O	O
a	O	O
multi	O	O
method	O	O
with	O	O
Disc	O	O
Pro	O	O
S	O	O
Se	O	O
(	O	O
D	O	O
)	O	O
windows	O	O
for	O	O
each	O	O
frequency	O	O
band	O	O
and	O	O
region	O	O
,	O	O
using	O	O
7	O	O
tape	O	O
at	O	O
4	O	O
Hz	O	O
and	O	O
regions	O	O
of	O	O
interest	O	O
based	O	O
on	O	O
the	O	O
Free	O	O
D	O	O
at	O	O
.	O	O
PS	O	O
represents	O	O
the	O	O
average	O	O
spectral	O	O
power	O	O
derived	O	O
from	O	O
each	O	O
v	O	O
time	O	O
series	O	O
for	O	O
each	O	O
regional	O	O
label	O	O
.	O	O
Global	O	O
measures	O	O
were	O	O
data	O	O
from	O	O
all	O	O
regional	O	O
labels	O	O
averaged	O	O
.	O	O
Normal	O	O
power	O	O
was	O	O
obtained	O	O
by	O	O
dividing	O	O
the	O	O
power	O	O
within	O	O
frequency	O	O
band	O	O
by	O	O
the	O	O
total	O	O
1	O	O
–	O	O
58	O	O
Hz	O	O
power	O	O
.	O	O
Fun	O	O
network	O	O
connectivity	O	O
was	O	O
estimated	O	O
using	O	O
a	O	O
de	O	O
est	O	O
of	O	O
the	O	O
squared	O	O
weighted	O	O
phase	O	O
la	O	O
index	O	O
(	O	O
w	O	O
)	O	O
.	O	O
The	O	O
F	O	O
measure	O	O
,	O	O
w	O	O
,	O	O
detect	O	O
true	O	O
changes	O	O
in	O	O
phase	O	O
,	O	O
while	O	O
reducing	O	O
the	O	O
influence	O	O
of	O	O
common	O	O
noise	O	O
sources	O	O
,	O	O
changes	O	O
in	O	O
phase	O	O
of	O	O
co	O	O
,	O	O
and	O	O
avoid	O	O
spur	O	O
increases	O	O
by	O	O
volume	O	O
.	O	O
It	O	O
estimates	O	O
the	O	O
extent	O	O
of	O	O
observed	O	O
phase	O	O
leads	O	O
and	O	O
la	O	O
by	O	O
the	O	O
magnitude	O	O
of	O	O
the	O	O
imaginary	O	O
component	O	O
of	O	O
the	O	O
cross	O	O
.	O	O
All	O	O
data	O	O
were	O	O
exported	O	O
to	O	O
MA	O	O
(	O	O
2018	O	O
,	O	O
Math	O	O
)	O	O
and	O	O
run	O	O
through	O	O
custom	O	O
scripts	O	O
.	O	O
In	O	O
Co	O	O
(	O	O
ICC	O	O
)	O	O
ICC	O	O
estimates	O	O
and	O	O
their	O	O
95	O	O
confidence	O	O
intervals	O	O
were	O	O
calculated	O	O
in	O	O
SP	O	O
to	O	O
assess	O	O
the	O	O
between	O	O
and	O	O
within	O	O
var	O	O
using	O	O
a	O	O
two	O	O
mixed	O	O
effects	O	O
model	O	O
with	O	O
absolute	O	O
agreement	O	O
,	O	O
single	O	O
measurement	O	O
criteria	O	O
,	O	O
also	O	O
known	O	O
as	O	O
ICC	O	O
(	O	O
3	O	O
)	O	O
model	O	O
.	O	O
ICC	O	O
were	O	O
calculated	O	O
for	O	O
multiple	O	O
rest	O	O
it	O	O
:	O	O
for	O	O
each	O	O
visit	O	O
(	O	O
across	O	O
one	O	O
hour	O	O
)	O	O
,	O	O
for	O	O
each	O	O
task	O	O
(	O	O
across	O	O
one	O	O
week	O	O
)	O	O
and	O	O
for	O	O
all	O	O
runs	O	O
.	O	O
ICC	O	O
ranged	O	O
from	O	O
0	O	O
to	O	O
1	O	O
(	O	O
negative	O	O
values	O	O
scored	O	O
as	O	O
zero	O	O
)	O	O
with	O	O
higher	O	O
values	O	O
indicating	O	O
better	O	O
reliability	O	O
.	O	O
Following	O	O
the	O	O
guidelines	O	O
of	O	O
we	O	O
defined	O	O
ICC	O	O
as	O	O
:	O	O
excellent	O	O
reliability	O	O
>	O	O
0	O	O
,	O	O
good	O	O
reliability	O	O
0	O	O
–	O	O
0	O	O
,	O	O
fair	O	O
reliability	O	O
0	O	O
–	O	O
0	O	O
,	O	O
and	O	O
poor	O	O
reliability	O	O
<	O	O
0	O	O
.	O	O
Statistical	O	O
Analysis	O	O
All	O	O
statistics	O	O
were	O	O
performed	O	O
using	O	O
SP	O	O
(	O	O
version	O	O
25	O	O
for	O	O
Macintosh	O	O
)	O	O
.	O	O
Mixed	O	O
Effect	O	O
Rep	O	O
Me	O	O
of	O	O
V	O	O
(	O	O
R	O	O
)	O	O
had	O	O
statistical	O	O
threshold	O	O
set	O	O
at	O	O
p	O	O
<	O	O
0	O	O
.	O	O
Green	O	O
correction	O	O
were	O	O
made	O	O
for	O	O
s	O	O
violations	O	O
.	O	O
The	O	O
between	O	O
factor	O	O
was	O	O
Group	O	O
(	O	O
HC	O	O
,	O	O
S	O	O
)	O	O
,	O	O
within	O	O
factors	O	O
included	O	O
Hemisphere	O	O
(	O	O
Left	O	O
,	O	O
Right	O	O
)	O	O
,	O	O
Rest	O	O
(	O	O
E	O	O
,	O	O
EC	O	O
)	O	O
,	O	O
and	O	O
/	O	O
or	O	O
Region	O	O
[	O	O
Superior	O	O
Pa	O	O
(	O	O
Su	O	O
)	O	O
,	O	O
In	O	O
Pa	O	O
(	O	O
In	O	O
)	O	O
,	O	O
Pre	O	O
]	O	O
depending	O	O
on	O	O
measure	O	O
explored	O	O
.	O	O
Sign	O	O
interactions	O	O
were	O	O
followed	O	O
with	O	O
separate	O	O
one	O	O
AN	O	O
,	O	O
or	O	O
t	O	O
on	O	O
the	O	O
factors	O	O
of	O	O
interest	O	O
with	O	O
family	O	O
multiple	O	O
comparisons	O	O
correction	O	O
using	O	O
false	O	O
discovery	O	O
rate	O	O
(	O	O
F	O	O
)	O	O
correction	O	O
with	O	O
q	O	O
=	O	O
0	O	O
.	O	O
Al	O	O
effects	O	O
on	O	O
g	O	O
p	O	O
connectivity	O	O
:	O	O
Role	O	O
of	O	O
imp	O	O
and	O	O
bin	O	O
drinking	O	O
Despite	O	O
the	O	O
harm	O	O
caused	O	O
by	O	O
bin	O	O
drinking	O	O
,	O	O
the	O	O
neural	O	O
mechanisms	O	O
leading	O	O
to	O	O
risky	O	O
and	O	O
di	O	O
into	O	O
behaviors	O	O
are	O	O
not	O	O
well	O	O
understood	O	O
.	O	O
Evidence	O	O
suggests	O	O
that	O	O
the	O	O
g	O	O
p	O	O
ex	O	O
(	O	O
GP	O	O
)	O	O
,	O	O
a	O	O
sub	O	O
within	O	O
the	O	O
basal	O	O
gang	O	O
,	O	O
participates	O	O
in	O	O
inhibitor	O	O
control	O	O
processes	O	O
,	O	O
as	O	O
examined	O	O
in	O	O
stop	O	O
tasks	O	O
.	O	O
In	O	O
fact	O	O
,	O	O
studies	O	O
in	O	O
rode	O	O
have	O	O
revealed	O	O
that	O	O
alcohol	O	O
can	O	O
change	O	O
GP	O	O
activity	O	O
by	O	O
decreasing	O	O
ne	O	O
firing	O	O
rates	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
GP	O	O
may	O	O
have	O	O
a	O	O
central	O	O
role	O	O
in	O	O
explaining	O	O
imp	O	O
behaviors	O	O
and	O	O
failures	O	O
of	O	O
in	O	O
that	O	O
occur	O	O
during	O	O
bin	O	O
drinking	O	O
.	O	O
In	O	O
this	O	O
study	O	O
,	O	O
twenty	O	O
healthy	B-NoKnownDisorder	O
volunteers	I-NoKnownDisorder	O
underwent	O	O
in	O	B-E
alcohol	O	I-E
in	O	I-E
to	O	O
achieve	O	O
a	O	O
blood	O	O
alcohol	O	O
level	O	O
of	O	O
0	O	O
g	O	O
/	O	O
d	O	O
,	O	O
which	O	O
is	O	O
equivalent	O	O
to	O	O
a	O	O
bin	O	O
drinking	O	O
episode	O	O
.	O	O
A	O	O
resting	B-RestingStateImaging	B-E
state	I-RestingStateImaging	I-E
functional	I-RestingStateImaging	I-E
magnetic	I-RestingStateImaging	I-E
resonance	I-RestingStateImaging	I-E
imaging	O	I-E
scan	O	I-E
was	O	O
collected	O	O
prior	O	O
to	O	O
the	O	O
in	O	O
and	O	O
at	O	O
bin	O	O
exposure	O	O
.	O	O
Fun	O	O
connectivity	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
investigate	O	O
the	O	O
association	O	O
between	O	O
alcohol	O	O
changes	O	O
in	O	O
GP	O	O
connectivity	O	O
,	O	O
drinking	O	O
behaviors	O	O
,	O	O
and	O	O
imp	O	O
traits	O	O
.	O	O
We	O	O
found	O	O
that	O	O
individuals	B-NondependentAlcoholAbuse	O
with	I-NondependentAlcoholAbuse	O
greater	I-NondependentAlcoholAbuse	O
number	I-NondependentAlcoholAbuse	O
of	I-NondependentAlcoholAbuse	O
drinks	I-NondependentAlcoholAbuse	O
or	I-NondependentAlcoholAbuse	O
heavy	I-NondependentAlcoholAbuse	O
drinking	I-NondependentAlcoholAbuse	O
days	I-NondependentAlcoholAbuse	O
in	O	O
the	O	O
recent	O	O
past	O	O
had	O	O
greater	O	O
alcohol	O	O
deficit	O	O
in	O	O
GP	O	O
connectivity	O	O
,	O	O
particularly	O	O
to	O	O
the	O	O
s	O	O
.	O	O
Our	O	O
data	O	O
also	O	O
indicated	O	O
an	O	O
association	O	O
between	O	O
imp	O	O
and	O	O
alcohol	O	O
deficit	O	O
in	O	O
GP	O	O
/	O	O
pre	O	O
connectivity	O	O
.	O	O
Moreover	O	O
,	O	O
alcohol	O	O
induced	O	O
changes	O	O
in	O	O
GP	O	O
circuit	O	O
suggested	O	O
greater	O	O
v	O	O
to	O	O
stress	O	O
drinking	O	O
in	O	O
some	O	O
individuals	O	O
.	O	O
Take	O	O
together	O	O
,	O	O
these	O	O
findings	O	O
suggest	O	O
that	O	O
alcohol	O	O
may	O	O
interact	O	O
with	O	O
imp	O	O
personality	O	O
traits	O	O
and	O	O
drinking	O	O
patterns	O	O
to	O	O
drive	O	O
alterations	O	O
in	O	O
GP	O	O
circuit	O	O
associated	O	O
with	O	O
behavioral	O	O
in	O	O
,	O	O
possibly	O	O
indicating	O	O
a	O	O
neural	O	O
mechanism	O	O
by	O	O
which	O	O
bin	O	O
drinking	O	O
could	O	O
lead	O	O
to	O	O
imp	O	O
behaviors	O	O
.	O	O
Method	B-StudyMethod	B-E
This	O	O
study	O	O
was	O	O
approved	O	O
by	O	O
the	O	O
N	O	B-E
Ad	O	O
Institution	O	O
Review	O	O
Board	O	O
under	O	O
12	O	O
-	O	O
AA	O	O
-	O	O
00	O	O
.	O	O
All	O	O
subjects	O	O
provided	O	O
written	O	O
informed	O	O
consent	O	O
prior	O	O
to	O	O
their	O	O
participation	O	O
in	O	O
the	O	O
study	O	O
.	O	O
Part	O	O
Twenty	O	O
healthy	B-NoKnownDisorder	O
(	I-NoKnownDisorder	O
13	I-NoKnownDisorder	O
males	I-NoKnownDisorder	O
,	I-NoKnownDisorder	O
12	I-NoKnownDisorder	O
females	I-NoKnownDisorder	O
;	I-NoKnownDisorder	O
mean	I-NoKnownDisorder	O
age	I-NoKnownDisorder	O
:	I-NoKnownDisorder	O
28	I-NoKnownDisorder	O
years	I-NoKnownDisorder	O
)	I-NoKnownDisorder	O
,	I-NoKnownDisorder	O
light	I-NoKnownDisorder	O
social	I-NoKnownDisorder	O
drink	I-NoKnownDisorder	O
were	O	O
recruited	O	O
by	O	O
local	O	O
advertisement	O	O
,	O	O
according	O	O
to	O	O
approved	O	O
National	O	O
Institutes	O	O
of	O	O
Health	O	O
Institution	O	O
Review	O	O
Board	O	O
procedures	O	O
.	O	O
The	O	O
demographic	O	O
data	O	O
of	O	O
participants	O	O
is	O	O
summarized	O	O
in	O	O
Table	O	O
1	O	O
.	O	O
After	O	O
obtaining	O	O
written	O	O
informed	O	O
consent	O	O
,	O	O
all	O	O
participants	O	O
underwent	O	O
a	O	O
comprehensive	O	O
medical	O	O
screen	O	O
,	O	O
including	O	O
blood	O	O
work	O	O
,	O	O
u	O	O
,	O	O
medical	O	O
history	O	O
,	O	O
physical	O	O
exam	O	O
,	O	O
and	O	O
a	O	O
Structure	B-StructuredClinicalInterviewforDSMDisorders	B-E
Clinical	I-StructuredClinicalInterviewforDSMDisorders	O
Interview	I-StructuredClinicalInterviewforDSMDisorders	O
for	I-StructuredClinicalInterviewforDSMDisorders	O
the	I-StructuredClinicalInterviewforDSMDisorders	O
DS	I-StructuredClinicalInterviewforDSMDisorders	B-E
Axis	I-StructuredClinicalInterviewforDSMDisorders	I-E
Di	I-StructuredClinicalInterviewforDSMDisorders	I-E
(	I-StructuredClinicalInterviewforDSMDisorders	I-E
SC	I-StructuredClinicalInterviewforDSMDisorders	I-E
)	I-StructuredClinicalInterviewforDSMDisorders	I-E
.	I-StructuredClinicalInterviewforDSMDisorders	O
C	O	O
for	O	O
inclusion	O	O
in	O	O
this	O	O
study	O	O
were	O	O
:	O	O
healthy	O	O
,	O	O
21	O	O
–	O	O
45	O	O
years	O	O
old	O	O
,	O	O
consumption	B-DrinkingEpisode	O
of	I-DrinkingEpisode	O
1	I-DrinkingEpisode	O
to	I-DrinkingEpisode	O
10	I-DrinkingEpisode	O
drinks	I-DrinkingEpisode	O
per	I-DrinkingEpisode	O
week	I-DrinkingEpisode	O
for	I-DrinkingEpisode	O
females	I-DrinkingEpisode	O
and	I-DrinkingEpisode	O
1	I-DrinkingEpisode	O
to	I-DrinkingEpisode	O
14	I-DrinkingEpisode	O
drinks	I-DrinkingEpisode	O
per	I-DrinkingEpisode	O
week	I-DrinkingEpisode	O
for	I-DrinkingEpisode	O
males	I-DrinkingEpisode	O
.	O	O
Sub	B-DrinkingSession	O
also	I-DrinkingSession	O
had	I-DrinkingSession	O
to	I-DrinkingSession	O
have	I-DrinkingSession	O
consumed	I-DrinkingSession	O
at	I-DrinkingSession	O
least	I-DrinkingSession	O
two	I-DrinkingSession	O
standard	I-DrinkingSession	O
drinks	I-DrinkingSession	O
of	I-DrinkingSession	O
alcohol	I-DrinkingSession	O
within	I-DrinkingSession	O
one	I-DrinkingSession	O
hour	I-DrinkingSession	O
on	I-DrinkingSession	O
at	I-DrinkingSession	O
least	I-DrinkingSession	O
one	I-DrinkingSession	O
occasion	I-DrinkingSession	O
in	I-DrinkingSession	O
their	I-DrinkingSession	O
lifetime	I-DrinkingSession	O
.	O	O
C	O	O
for	O	O
exclusion	O	O
included	O	O
:	O	O
abnormal	O	O
blood	O	O
or	O	O
urine	O	O
lab	O	O
test	O	O
values	O	O
or	O	O
findings	O	O
from	O	O
the	O	O
medical	O	O
screen	O	O
,	O	O
DS	O	O
criteria	O	O
for	O	O
alcohol	O	O
or	O	O
other	O	O
substance	O	O
dependence	O	O
(	O	O
excluding	O	O
ni	O	O
)	O	O
at	O	O
any	O	O
time	O	O
;	O	O
current	O	O
or	O	O
past	O	O
major	O	O
psychiatric	O	O
disorder	O	O
(	O	O
DS	O	O
Axis	O	O
I	O	I-E
)	O	O
,	O	O
head	O	O
injury	O	O
requiring	O	O
hospital	O	O
,	O	O
Body	O	O
Mass	O	I-E
Index	O	I-E
(	O	I-E
B	O	I-E
)	O	I-E
value	O	O
over	O	O
30	O	O
,	O	O
inability	O	O
to	O	O
stop	O	O
taking	O	O
any	O	O
medication	O	O
or	O	O
drugs	O	O
3	O	O
days	O	O
prior	O	O
to	O	O
study	O	O
days	O	O
,	O	O
and	O	O
MR	O	O
con	O	O
.	O	O
Also	O	O
,	O	O
non	O	O
were	O	O
excluded	O	O
from	O	O
the	O	O
study	O	O
due	O	O
to	O	O
ethical	O	O
concerns	O	O
related	O	O
to	O	O
alcohol	O	O
administration	O	O
.	O	O
De	O	O
,	O	O
drinking	O	O
,	O	O
and	O	O
imp	O	O
characteristics	O	O
.	O	O
V	O	O
Count	O	O
Total	O	O
n	O	O
25	O	O
Gender	O	O
(	O	O
Male	O	O
/	O	O
Female	O	O
)	O	O
13	O	O
/	O	O
12	O	O
Smoke	O	O
1	O	O
Mean	O	O
SD	O	O
Age	O	O
28	O	O
7	O	O
Years	O	O
Of	O	O
Education	O	O
15	O	O
1	O	O
B	O	O
:	O	O
Total	O	O
54	O	O
9	O	O
At	O	O
I	O	O
12	O	O
2	O	O
Motor	O	O
I	O	O
20	O	O
3	O	O
Non	O	I-E
I	O	I-E
19	O	O
4	O	O
UP	O	I-E
:	O	I-E
Po	O	I-E
U	O	I-E
1	O	I-E
0	O	O
N	O	I-E
U	O	I-E
1	O	O
0	O	O
Pre	O	O
1	O	O
0	O	O
Per	O	O
1	O	O
0	O	O
Sen	O	O
See	O	I-E
2	O	O
0	O	O
Del	O	O
Disco	O	O
Rate	O	O
(	O	O
K	O	O
)	O	O
0	O	O
0	O	O
T	O	O
Per	O	O
Thirty	O	O
Days	O	O
20	O	O
13	O	O
T	O	O
Dr	O	I-E
Days	O	I-E
19	O	O
10	O	O
A	O	O
as	O	O
follow	O	O
:	O	O
B	B-ImpulsivityScale	B-E
-	I-ImpulsivityScale	O
Barr	I-ImpulsivityScale	O
I	I-ImpulsivityScale	I-E
Scale	I-ImpulsivityScale	I-E
;	O	I-E
T	B-MentalHealthDiagnosisScale	I-E
-	I-MentalHealthDiagnosisScale	O
Al	I-MentalHealthDiagnosisScale	O
Time	I-MentalHealthDiagnosisScale	I-E
Follow	I-MentalHealthDiagnosisScale	I-E
.	O	I-E
Me	O	O
Al	O	O
drinking	O	O
measures	O	O
The	O	O
amount	O	O
of	O	O
daily	O	O
alcohol	O	O
consumption	O	O
over	O	O
the	O	O
last	O	O
90	O	O
days	O	O
was	O	O
measured	O	O
using	O	O
the	O	O
Al	B-AlcoholUseQuestionnaire	B-E
Time	I-AlcoholUseQuestionnaire	I-E
(	I-AlcoholUseQuestionnaire	I-E
T	I-AlcoholUseQuestionnaire	I-E
)	I-AlcoholUseQuestionnaire	I-E
calendar	O	O
drinking	O	O
assessment	O	O
method	O	O
with	O	O
good	O	O
ps	O	O
characteristics	O	O
for	O	O
est	O	O
retrospective	O	O
daily	O	O
drinking	O	O
patterns	O	O
.	O	O
The	O	O
number	O	O
of	O	O
heavy	O	O
drinking	O	O
days	O	O
in	O	O
the	O	O
last	O	O
90	O	O
days	O	O
was	O	O
calculated	O	O
from	O	O
the	O	O
T	B-AlcoholUseQuestionnaire	O
;	O	O
a	O	O
heavy	O	O
drinking	O	O
day	O	O
is	O	O
defined	O	O
as	O	O
4	O	O
or	O	O
more	O	O
drinks	O	O
per	O	O
day	O	O
for	O	O
women	O	O
and	O	O
5	O	O
or	O	O
more	O	O
drinks	O	O
per	O	O
day	O	O
for	O	O
men	O	O
.	O	O
We	O	O
used	O	O
this	O	O
as	O	O
a	O	O
measure	O	O
for	O	O
bin	B-DrinkingBinge	O
drinking	I-DrinkingBinge	O
.	O	O
Total	O	O
drinks	O	O
in	O	O
the	O	O
past	O	O
30	O	O
days	O	O
was	O	O
also	O	O
calculated	O	O
from	O	O
the	O	O
T	B-AlcoholUseQuestionnaire	O
.	O	O
Past	B-DrinkingDay	O
30	I-DrinkingDay	O
-	I-DrinkingDay	O
day	I-DrinkingDay	O
drinking	I-DrinkingDay	O
was	I-DrinkingDay	O
used	I-DrinkingDay	O
rather	I-DrinkingDay	O
than	I-DrinkingDay	O
90	I-DrinkingDay	O
-	I-DrinkingDay	O
day	I-DrinkingDay	O
drinking	I-DrinkingDay	O
given	I-DrinkingDay	O
that	I-DrinkingDay	O
we	I-DrinkingDay	O
were	I-DrinkingDay	O
interested	I-DrinkingDay	O
in	I-DrinkingDay	O
recent	I-DrinkingDay	O
drinking	I-DrinkingDay	O
,	I-DrinkingDay	O
and	I-DrinkingDay	O
that	I-DrinkingDay	O
recent	I-DrinkingDay	O
reports	I-DrinkingDay	O
of	I-DrinkingDay	O
drinking	I-DrinkingDay	O
may	I-DrinkingDay	O
be	I-DrinkingDay	O
more	I-DrinkingDay	O
reliable	I-DrinkingDay	O
.	I-DrinkingDay	O
I	O	O
measures	O	O
I	O	O
behavioral	O	O
traits	O	O
were	O	O
measured	O	O
using	O	O
the	O	O
Barr	B-ImpulsivityScale	B-E
I	I-ImpulsivityScale	I-E
Scale	I-ImpulsivityScale	I-E
(	I-ImpulsivityScale	I-E
B	I-ImpulsivityScale	I-E
-	I-ImpulsivityScale	I-E
11	I-ImpulsivityScale	I-E
)	I-ImpulsivityScale	I-E
and	O	O
the	O	O
UP	B-ImpulsivityScale	B-E
I	I-ImpulsivityScale	I-E
Be	I-ImpulsivityScale	I-E
Scale	I-ImpulsivityScale	I-E
,	O	O
two	O	O
of	O	O
the	O	O
most	O	O
widely	O	O
self	O	O
tools	O	O
in	O	O
the	O	O
evaluation	O	O
of	O	O
trait	O	O
imp	O	O
.	O	O
The	O	O
B	B-ImpulsivityScale	B-E
-	I-ImpulsivityScale	I-E
11	I-ImpulsivityScale	I-E
scale	O	I-E
evaluate	O	O
imp	O	O
behavior	O	O
in	O	O
general	O	O
,	O	O
and	O	O
the	O	O
motor	O	O
,	O	O
attention	O	O
and	O	O
non	O	O
sub	O	O
evaluate	O	O
acting	O	O
without	O	O
thinking	O	O
,	O	O
inability	O	O
to	O	O
focus	O	O
attention	O	O
and	O	O
lack	O	O
of	O	O
fore	O	O
,	O	O
respectively	O	O
.	O	O
The	O	O
UP	B-ImpulsivityScale	O
measures	O	O
personality	O	O
traits	O	O
con	O	O
to	O	O
imp	O	O
behavior	O	O
including	O	O
U	O	O
(	O	O
negative	O	O
)	O	O
—	O	O
tendency	O	O
to	O	O
imp	O	O
act	O	O
under	O	O
strong	O	O
negative	O	O
emotions	O	O
,	O	O
Pre	O	O
(	O	O
lack	O	O
of	O	O
)	O	O
—	O	O
tendency	O	O
to	O	O
act	O	O
without	O	O
thinking	O	O
,	O	O
Per	O	O
(	O	O
lack	O	O
of	O	O
)	O	O
to	O	O
remain	O	O
focused	O	O
on	O	O
a	O	O
task	O	O
,	O	O
Sen	O	O
to	O	O
seek	O	O
out	O	O
novel	O	O
/	O	O
thrill	O	O
experiences	O	O
,	O	O
and	O	O
Po	O	O
to	O	O
imp	O	O
act	O	O
under	O	O
strong	O	O
positive	O	O
emotions	O	O
.	O	O
We	O	O
also	O	O
evaluated	O	O
choice	O	O
imp	O	O
with	O	O
the	O	O
Del	B-ImpulsivityScale	B-E
Disco	I-ImpulsivityScale	I-E
Task	I-ImpulsivityScale	I-E
(	I-ImpulsivityScale	I-E
DD	I-ImpulsivityScale	I-E
)	I-ImpulsivityScale	I-E
.	O	O
The	O	O
DD	B-ImpulsivityScale	O
measures	O	O
imp	O	O
by	O	O
presenting	O	O
the	O	O
subject	O	O
with	O	O
a	O	O
series	O	O
of	O	O
h	O	O
choices	O	O
between	O	O
receiving	O	O
a	O	O
smaller	O	O
immediate	O	O
monetary	O	O
reward	O	O
or	O	O
a	O	O
larger	O	O
delayed	O	O
reward	O	O
.	O	O
Sub	O	O
were	O	O
presented	O	O
as	O	O
their	O	O
immediate	O	O
reward	O	O
values	O	O
between	O	O
$	O	O
and	O	O
$	O	O
dollars	O	O
in	O	O
in	O	O
of	O	O
$	O	O
,	O	O
while	O	O
the	O	O
delayed	O	O
reward	O	O
was	O	O
$	O	O
.	O	O
Del	O	O
were	O	O
0	O	O
,	O	O
7	O	O
,	O	O
14	O	O
,	O	O
20	O	O
,	O	O
25	O	O
,	O	O
or	O	O
30	O	O
days	O	O
.	O	O
Sub	O	O
completed	O	O
trials	O	O
with	O	O
all	O	O
it	O	O
of	O	O
these	O	O
parameters	O	O
.	O	O
The	O	O
rate	O	O
of	O	O
discount	O	O
of	O	O
the	O	O
delayed	O	O
outcome	O	O
(	O	O
k	O	O
)	O	O
was	O	O
calculated	O	O
and	O	O
then	O	O
a	O	O
natural	O	O
log	O	O
was	O	O
applied	O	O
to	O	O
correct	O	O
for	O	O
the	O	O
non	O	O
distribution	O	O
of	O	O
k	O	O
values	O	O
.	O	O
The	O	O
resulting	O	O
l	O	O
(	O	O
k	O	O
)	O	O
is	O	O
used	O	O
to	O	O
represent	O	O
delay	O	O
discount	O	O
,	O	O
where	O	O
higher	O	O
l	O	O
(	O	O
k	O	O
)	O	O
values	O	O
mean	O	O
greater	O	O
preference	O	O
for	O	O
immediate	O	O
rewards	O	O
(	O	O
see	O	O
Table	O	O
1	O	O
for	O	O
descriptive	O	O
statistics	O	O
of	O	O
drinking	O	O
and	O	O
imp	O	O
scores	O	O
for	O	O
the	O	O
sample	O	O
)	O	O
.	O	O
Experimental	O	O
design	O	O
and	O	O
statistical	O	O
analysis	O	O
Overall	O	O
timeline	O	O
In	O	O
this	O	O
two	O	O
study	O	O
,	O	O
healthy	O	O
light	O	O
drink	O	O
received	O	O
an	O	O
IV	O	O
alcohol	O	O
in	O	O
on	O	O
two	O	O
separate	O	O
days	O	O
.	O	O
The	O	O
first	O	O
session	O	O
was	O	O
conducted	O	O
outside	O	O
the	O	O
scan	O	O
to	O	O
establish	O	O
the	O	O
alcohol	O	O
in	O	O
rate	O	O
profile	O	O
to	O	O
achieve	O	O
and	O	O
maintain	O	O
the	O	O
target	O	O
B	O	O
exposure	O	O
,	O	O
and	O	O
to	O	O
ensure	O	O
to	O	O
.	O	O
The	O	O
alcohol	O	O
in	O	O
for	O	O
the	O	O
second	O	O
session	O	O
was	O	O
conducted	O	O
inside	O	O
the	O	O
scan	O	O
at	O	O
least	O	O
three	O	O
days	O	O
after	O	O
the	O	O
first	O	O
session	O	O
(	O	O
Fi	O	O
1	O	O
)	O	O
.	O	O
Part	O	O
were	O	O
asked	O	O
to	O	O
fast	O	O
the	O	O
night	O	O
before	O	O
each	O	O
session	O	O
.	O	O
At	O	O
the	O	O
start	O	O
of	O	O
each	O	O
visit	O	O
,	O	O
breath	O	O
alcohol	O	O
levels	O	O
,	O	O
urine	O	O
pregnancy	O	O
tests	O	O
(	O	O
if	O	O
applicable	O	O
)	O	O
and	O	O
urine	O	O
drug	O	O
screens	O	O
were	O	O
collected	O	O
.	O	O
In	O	O
addition	O	O
,	O	O
we	O	O
conducted	O	O
a	O	O
brief	O	O
history	O	O
interview	O	O
about	O	O
recent	O	O
alcohol	O	O
,	O	O
medication	O	O
,	O	O
and	O	O
ni	O	O
use	O	O
,	O	O
changes	O	O
in	O	O
physical	O	O
health	O	O
,	O	O
and	O	O
men	O	O
(	O	O
if	O	O
applicable	O	O
)	O	O
.	O	O
Time	O	O
of	O	O
in	O	O
alcohol	O	O
in	O	O
study	O	O
.	O	O
The	O	O
timeline	O	O
depiction	O	O
of	O	O
the	O	O
two	O	O
in	O	O
alcohol	O	O
in	O	O
study	O	O
;	O	O
sessions	O	O
were	O	O
separated	O	O
at	O	O
least	O	O
three	O	O
days	O	O
from	O	O
each	O	O
other	O	O
.	O	O
The	O	O
session	O	O
2	O	O
timeline	O	O
indicates	O	O
time	O	O
of	O	O
resting	O	O
state	O	O
and	O	O
BA	O	O
measurement	O	O
alongside	O	O
IV	O	O
in	O	O
;	O	O
the	O	O
first	O	O
resting	O	B-E
state	O	I-E
scan	O	O
occurred	O	O
before	O	O
the	O	O
IV	O	O
in	O	O
at	O	O
blood	O	O
alcohol	O	O
level	O	O
of	O	O
0	O	O
g	O	O
/	O	O
d	O	O
and	O	O
the	O	O
second	O	O
one	O	O
was	O	O
collected	O	O
when	O	O
the	O	O
blood	O	O
alcohol	O	O
level	O	O
reached	O	O
the	O	O
bin	O	O
levels	O	O
(	O	O
0	O	O
g	O	O
/	O	O
d	O	O
)	O	O
.	O	O
Al	O	O
in	O	O
to	O	O
bin	O	O
level	O	O
exposure	O	O
We	O	O
performed	O	O
the	O	O
alcohol	O	B-E
in	O	O
procedure	O	O
following	O	O
previously	O	O
published	O	O
methods	O	O
(	O	O
f	B-FunctionalMagneticResonanceImaging	B-E
and	O	O
P	B-PositronEmissionTomography	O
)	O	O
.	O	O
In	O	O
both	O	O
sessions	O	O
,	O	O
participants	O	O
received	O	O
an	O	O
in	O	O
(	O	O
IV	O	O
)	O	O
in	O	O
of	O	O
6	O	O
v	O	O
/	O	O
v	O	O
ethanol	O	O
solution	O	O
in	O	O
sa	O	O
to	O	O
achieve	O	O
a	O	O
target	O	O
breath	O	O
alcohol	O	O
concentration	O	O
(	O	O
B	O	O
)	O	O
of	O	O
0	O	O
±	O	O
0	O	O
g	O	O
/	O	O
d	O	O
at	O	O
15	O	O
min	O	O
after	O	O
the	O	O
start	O	O
of	O	O
the	O	O
in	O	O
,	O	O
and	O	O
to	O	O
maintain	O	O
(	O	O
or	O	O
c	O	O
)	O	O
the	O	O
target	O	O
B	O	O
level	O	O
for	O	O
30	O	O
min	O	O
(	O	O
Fi	O	O
1	O	O
)	O	O
.	O	O
The	O	O
in	O	O
profile	O	O
was	O	O
com	O	O
for	O	O
each	O	O
subject	O	O
using	O	O
a	O	O
physiological	O	O
p	O	O
(	O	O
P	O	O
)	O	O
model	O	O
algorithm	O	O
,	O	O
with	O	O
individual	O	O
estimates	O	O
of	O	O
the	O	O
model	O	O
parameters	O	O
estimated	O	O
from	O	O
the	O	O
subject	O	O
’	O	O
s	O	O
height	O	O
,	O	O
weight	O	O
,	O	O
age	O	O
and	O	O
sex	O	O
.	O	O
During	O	O
the	O	O
first	O	O
session	O	O
conducted	O	O
outside	O	O
the	O	O
scan	O	O
,	O	O
serial	O	O
B	O	O
were	O	O
measured	O	O
at	O	O
frequent	O	O
intervals	O	O
(	O	O
5	O	O
–	O	O
15	O	O
minutes	O	O
)	O	O
using	O	O
the	O	O
Al	O	O
74	O	O
+	O	O
hand	O	O
breath	O	O
(	O	O
Dr	O	O
Safety	O	O
Inc	O	O
.	O	O
,	O	O
CO	O	O
)	O	O
,	O	O
to	O	O
ensure	O	O
that	O	O
each	O	O
B	O	O
was	O	O
within	O	O
0	O	O
g	O	O
/	O	O
d	O	O
of	O	O
the	O	O
target	O	O
,	O	O
and	O	O
to	O	O
enable	O	O
minor	O	O
adjustments	O	O
to	O	O
the	O	O
in	O	O
rates	O	O
to	O	O
overcome	O	O
errors	O	O
in	O	O
parameter	O	O
est	O	O
and	O	O
experimental	O	O
var	O	O
.	O	O
The	O	O
adjusted	O	O
in	O	O
rate	O	O
profile	O	O
from	O	O
the	O	O
first	O	O
session	O	O
was	O	O
used	O	O
in	O	O
the	O	O
imaging	O	O
session	O	O
to	O	O
replica	O	O
the	O	O
target	O	O
B	O	O
profile	O	O
for	O	O
each	O	O
subject	O	O
.	O	O
This	O	O
approach	O	O
has	O	O
been	O	O
used	O	O
to	O	O
successfully	O	O
achieve	O	O
and	O	O
maintain	O	O
target	O	O
B	O	O
,	O	O
as	O	O
verified	O	O
by	O	O
blood	O	O
alcohol	O	O
concentrations	O	O
measured	O	O
in	O	O
samples	O	O
drawn	O	O
during	O	O
the	O	O
scan	O	O
in	O	O
other	O	O
ne	O	O
studies	O	O
.	O	O
After	O	O
the	O	O
end	O	O
of	O	O
the	O	O
in	O	O
,	O	O
subjects	O	O
were	O	O
provided	O	O
a	O	O
meal	O	O
,	O	O
and	O	O
B	O	O
was	O	O
tracked	O	O
until	O	O
it	O	O
dropped	O	O
to	O	O
0	O	O
g	O	O
/	O	O
d	O	O
or	O	O
below	O	O
,	O	O
at	O	O
which	O	O
time	O	O
subjects	O	O
were	O	O
taken	O	O
home	O	O
by	O	O
a	O	O
designated	O	O
driver	O	O
or	O	O
taxi	O	O
.	O	O
N	O	O
acquisition	O	O
and	O	O
pre	O	O
During	O	O
session	O	O
2	O	O
,	O	O
after	O	O
the	O	O
IV	O	O
cat	O	O
were	O	O
placed	O	O
for	O	O
alcohol	O	O
in	O	O
,	O	O
participants	O	O
were	O	O
placed	O	O
in	O	O
a	O	O
3	O	O
S	O	O
Sky	O	O
MR	O	O
scan	O	O
at	O	O
the	O	O
N	O	O
Research	O	O
Center	O	O
at	O	O
the	O	O
N	O	O
.	O	O
Before	O	O
starting	O	O
the	O	O
IV	O	O
in	O	O
of	O	O
alcohol	O	O
,	O	O
a	O	O
5	O	O
-	O	O
min	O	O
closed	B-RestingStateImaging	O
eyes	I-RestingStateImaging	O
resting	I-RestingStateImaging	B-E
f	I-RestingStateImaging	I-E
scan	O	I-E
was	O	O
acquired	O	O
with	O	O
an	O	O
echo	O	O
imaging	O	I-E
sequence	O	I-E
(	O	O
36	O	O
a	O	O
slice	O	O
,	O	O
3	O	O
mm	O	O
thickness	O	O
,	O	O
64	O	O
×	O	O
64	O	O
matrix	O	O
and	O	O
repetition	O	O
time	O	O
of	O	O
2000	O	O
m	O	O
,	O	O
echo	O	O
time	O	O
30	O	O
,	O	O
flip	O	O
angle	O	O
90	O	O
)	O	O
.	O	O
After	O	O
collecting	O	O
this	O	O
base	O	O
resting	B-RestingStateImaging	B-E
f	I-RestingStateImaging	I-E
scan	O	I-E
,	O	O
the	O	O
alcohol	O	O
in	O	O
started	O	O
and	O	O
once	O	O
the	O	O
target	O	O
BA	O	O
was	O	O
achieved	O	O
,	O	O
a	O	O
10	O	O
-	O	O
minute	O	O
waiting	O	O
period	O	O
was	O	O
allowed	O	O
to	O	O
ensure	O	O
the	O	O
BA	O	O
was	O	O
stable	O	O
at	O	O
the	O	O
0	O	O
g	O	O
/	O	O
d	O	O
level	O	O
.	O	O
During	O	O
the	O	O
waiting	O	O
period	O	O
,	O	O
whole	B-StructuralImaging	O
structural	I-StructuralImaging	O
and	O	O
diffusion	B-DiffusionWeightedImaging	O
images	I-DiffusionWeightedImaging	O
of	O	O
the	O	O
brain	O	O
were	O	O
collected	O	O
.	O	O
Then	O	O
,	O	O
a	O	O
second	O	O
eyes	B-RestingStateImaging	B-E
resting	I-RestingStateImaging	B-E
f	I-RestingStateImaging	I-E
scan	O	I-E
was	O	O
collected	O	O
while	O	O
the	O	O
target	O	O
BA	O	O
(	O	O
0	O	O
g	O	O
/	O	O
d	O	O
)	O	O
was	O	O
maintained	O	O
.	O	O
Following	O	O
the	O	O
MR	B-RestingStateImaging	B-E
session	O	I-E
,	O	O
the	O	O
Drug	B-Questionnaire	B-E
Effects	I-Questionnaire	I-E
Question	I-Questionnaire	I-E
was	O	O
used	O	O
to	O	O
evaluate	O	O
and	O	O
q	O	O
subjective	O	O
effects	O	O
of	O	O
alcohol	O	O
(	O	O
DE	O	O
)	O	O
.	O	O
CO	O	O
ve	O	O
.	O	O
(	O	O
http	O	O
:	O	O
/	O	O
/	O	O
www	O	O
)	O	O
,	O	O
a	O	O
MA	O	O
/	O	O
SP	O	O
(	O	O
www	O	O
/	O	O
s	O	O
/	O	O
)	O	O
software	O	O
,	O	O
was	O	O
used	O	O
to	O	O
conduct	O	O
spatial	O	O
/	O	O
temporal	O	O
pre	O	O
and	O	O
analyses	O	O
.	O	O
Spa	O	O
pre	O	O
included	O	O
slice	O	O
correction	O	O
,	O	O
real	O	O
,	O	O
co	O	O
,	O	O
normal	O	O
,	O	O
and	O	O
spatial	O	O
smooth	O	O
(	O	O
8	O	O
mm	O	O
)	O	O
.	O	O
Using	O	O
the	O	O
default	O	O
settings	O	O
in	O	O
CO	O	O
,	O	O
images	O	O
were	O	O
re	O	O
into	O	O
is	O	O
2	O	O
v	O	O
.	O	O
Ana	O	O
volumes	O	O
were	O	O
segment	O	O
into	O	O
grey	O	O
matter	O	O
,	O	O
white	O	O
matter	O	O
,	O	O
and	O	O
c	O	O
fluid	O	O
(	O	O
CS	O	O
)	O	O
areas	O	O
and	O	O
the	O	O
resulting	O	O
masks	O	O
were	O	O
eroded	O	O
to	O	O
minimize	O	O
partial	O	O
volume	O	O
effects	O	O
.	O	O
At	O	O
the	O	O
individual	O	O
level	O	O
,	O	O
the	O	O
temporal	O	O
times	O	O
of	O	O
the	O	O
participant	O	O
six	O	O
rotation	O	O
motion	O	O
parameters	O	O
and	O	O
the	O	O
times	O	O
from	O	O
within	O	O
the	O	O
white	O	O
matter	O	O
/	O	O
CS	O	O
masks	O	O
were	O	O
used	O	O
as	O	O
temporal	O	O
co	O	O
,	O	O
and	O	O
removed	O	O
from	O	O
the	O	O
blood	O	O
oxygen	O	O
level	O	O
(	O	O
B	O	O
)	O	O
functional	O	O
data	O	O
using	O	O
linear	O	O
re	O	O
.	O	O
The	O	O
resulting	O	O
residual	O	O
B	O	O
times	O	O
were	O	O
band	O	O
filtered	O	O
(	O	O
0	O	O
<	O	O
f	O	O
<	O	O
0	O	O
)	O	O
.	O	O
N	O	O
analysis	O	O
To	O	O
our	O	O
knowledge	O	O
there	O	O
is	O	O
no	O	O
reported	O	O
sub	O	O
of	O	O
human	O	O
GP	O	O
with	O	O
concrete	O	O
landmark	O	O
definition	O	O
and	O	O
/	O	O
or	O	O
Ta	O	O
coordinate	O	O
dem	O	O
.	O	O
Therefore	O	O
,	O	O
for	O	O
these	O	O
analyses	O	O
,	O	O
we	O	O
used	O	O
right	O	O
and	O	O
left	O	O
GP	O	O
masks	O	O
obtained	O	O
from	O	O
the	O	O
Lead	O	O
tool	O	O
(	O	O
http	O	O
:	O	O
/	O	O
/	O	O
www	O	O
/	O	O
)	O	O
.	O	O
These	O	O
an	O	O
masks	O	O
were	O	O
generated	O	O
using	O	O
manual	O	O
tracing	O	O
of	O	O
several	O	O
structural	O	O
MR	O	O
and	O	O
subsequent	O	O
co	O	O
with	O	O
his	O	O
studies	O	O
,	O	O
and	O	O
have	O	O
a	O	O
combined	O	O
volume	O	O
of	O	O
approximately	O	O
92	O	O
mm	O	O
.	O	O
See	O	O
correlation	O	O
were	O	O
calculated	O	O
as	O	O
Fisher	O	O
bi	O	O
correlation	O	O
coefficients	O	O
between	O	O
the	O	O
B	O	O
activity	O	O
times	O	O
in	O	O
the	O	O
seed	O	O
R	O	O
and	O	O
each	O	O
other	O	O
individual	O	O
v	O	O
B	O	O
.	O	O
CS	O	O
,	O	O
grey	O	O
matter	O	O
,	O	O
white	O	O
matter	O	O
signals	O	O
and	O	O
motion	O	O
were	O	O
included	O	O
as	O	O
co	O	O
for	O	O
this	O	O
model	O	O
at	O	O
the	O	O
single	O	O
subject	O	O
level	O	O
.	O	O
These	O	O
correlation	O	O
were	O	O
calculated	O	O
separately	O	O
for	O	O
the	O	O
pre	O	O
and	O	O
post	O	O
scan	O	O
and	O	O
for	O	O
right	O	O
and	O	O
left	O	O
GP	O	O
seeds	O	O
.	O	O
For	O	O
each	O	O
of	O	O
the	O	O
pre	O	O
-	O	O
and	O	O
post	O	O
analyses	O	O
,	O	O
150	O	O
time	O	O
points	O	O
(	O	O
across	O	O
300	O	O
seconds	O	O
)	O	O
were	O	O
used	O	O
.	O	O
To	O	O
examine	O	O
group	O	O
level	O	O
effects	O	O
,	O	O
the	O	O
resulting	O	O
single	O	O
connectivity	O	O
maps	O	O
were	O	O
used	O	O
as	O	O
input	O	O
for	O	O
second	O	O
level	O	O
analyses	O	O
in	O	O
a	O	O
general	O	O
linear	O	O
model	O	O
.	O	O
We	O	O
modeled	O	O
the	O	O
within	O	O
effect	O	O
of	O	O
time	O	O
(	O	O
i	O	O
.	O	O
,	O	O
post	O	O
-	O	O
versus	O	O
pre	O	O
in	O	O
;	O	O
see	O	O
S	O	O
File	O	O
,	O	O
S	O	O
Fi	O	O
and	O	O
S	O	O
Table	O	O
for	O	O
report	O	O
of	O	O
the	O	O
main	O	O
effects	O	O
of	O	O
alcohol	O	O
administration	O	O
)	O	O
and	O	O
between	O	O
effects	O	O
of	O	O
imp	O	O
(	O	O
B	O	O
-	O	O
11	O	O
,	O	O
UP	O	O
,	O	O
and	O	O
DD	O	O
)	O	O
and	O	O
recent	O	O
drinking	O	O
behaviors	O	O
(	O	O
number	O	O
of	O	O
drinks	O	O
in	O	O
the	O	O
last	O	O
30	O	O
days	O	O
,	O	O
number	O	O
of	O	O
heavy	O	O
drinking	O	O
days	O	O
)	O	O
.	O	O
S	O	O
Table	O	O
indicates	O	O
clusters	O	O
identified	O	O
as	O	O
showing	O	O
significant	O	O
changes	O	O
from	O	O
pre	O	O
to	O	O
post	O	O
alcohol	O	O
in	O	O
,	O	O
as	O	O
well	O	O
as	O	O
associated	O	O
statistics	O	O
.	O	O
For	O	O
the	O	O
seed	O	O
analysis	O	O
,	O	O
reported	O	O
clusters	O	O
survived	O	O
a	O	O
height	O	O
threshold	O	O
of	O	O
un	O	O
p	O	O
<	O	O
0	O	O
with	O	O
a	O	O
cluster	O	O
level	O	O
extent	O	O
threshold	O	O
of	O	O
F	O	O
p	O	O
<	O	O
0	O	O
.	O	O
In	O	O
Fi	O	O
3	O	O
–	O	O
5	O	O
,	O	O
these	O	O
clusters	O	O
are	O	O
shown	O	O
over	O	O
on	O	O
structural	O	O
brain	O	O
cut	O	O
.	O	O
Co	O	O
line	O	O
plots	O	O
are	O	O
only	O	O
for	O	O
visual	O	O
interpretation	O	O
of	O	O
these	O	O
effects	O	O
.	O	O
We	O	O
also	O	O
examined	O	O
sex	O	O
effects	O	O
on	O	O
alcohol	O	O
changes	O	O
in	O	O
GP	O	O
connectivity	O	O
at	O	O
the	O	O
whole	O	O
brain	O	O
level	O	O
;	O	O
there	O	O
were	O	O
no	O	O
significant	O	O
differences	O	O
between	O	O
males	O	O
and	O	O
females	O	O
.	O	O
In	O	O
order	O	O
to	O	O
test	O	O
our	O	O
hypothesis	O	O
that	O	O
the	O	O
interaction	O	O
between	O	O
recent	O	O
drinking	O	O
behaviors	O	O
and	O	O
imp	O	O
would	O	O
contribute	O	O
to	O	O
alcohol	O	O
changes	O	O
in	O	O
GP	O	O
functional	O	O
connectivity	O	O
,	O	O
we	O	O
extracted	O	O
R	O	O
correlation	O	O
values	O	O
between	O	O
the	O	O
seeds	O	O
and	O	O
significant	O	O
clusters	O	O
and	O	O
used	O	O
those	O	O
values	O	O
to	O	O
conduct	O	O
multiple	O	O
re	O	O
analysis	O	O
in	O	O
R	O	O
/	O	O
RS	O	O
(	O	O
version	O	O
3	O	O
/	O	O
1	O	O
)	O	O
.	O	O
We	O	O
modeled	O	O
drinking	O	O
history	O	O
,	O	O
imp	O	O
,	O	O
and	O	O
the	O	O
interaction	O	O
between	O	O
the	O	O
two	O	O
as	O	O
independent	O	O
variables	O	O
on	O	O
the	O	O
dependent	O	O
variable	O	O
of	O	O
change	O	O
in	O	O
GP	O	O
connectivity	O	O
.	O	O
We	O	O
conducted	O	O
these	O	O
analyses	O	O
only	O	O
for	O	O
significant	O	O
clusters	O	O
identified	O	O
in	O	O
the	O	O
seed	O	O
analysis	O	O
,	O	O
and	O	O
only	O	O
for	O	O
the	O	O
significant	O	O
drinking	O	O
and	O	O
imp	O	O
measures	O	O
.	O	O
For	O	O
the	O	O
drinking	O	O
measures	O	O
identified	O	O
in	O	O
that	O	O
seed	O	O
analysis	O	O
,	O	O
models	O	O
(	O	O
for	O	O
the	O	O
specific	O	O
significant	O	O
cluster	O	O
only	O	O
)	O	O
included	O	O
the	O	O
significant	O	O
drinking	O	O
variable	O	O
as	O	O
well	O	O
as	O	O
one	O	O
of	O	O
the	O	O
two	O	O
significant	O	O
imp	O	O
variables	O	O
;	O	O
thus	O	O
,	O	O
2	O	O
re	O	O
per	O	O
cluster	O	O
were	O	O
run	O	O
.	O	O
Similarly	O	O
,	O	O
for	O	O
significant	O	O
imp	O	O
measures	O	O
,	O	O
2	O	O
re	O	O
per	O	O
cluster	O	O
were	O	O
run	O	O
(	O	O
as	O	O
there	O	O
are	O	O
two	O	O
drinking	O	O
variables	O	O
)	O	O
.	O	O
This	O	O
resulted	O	O
in	O	O
a	O	O
total	O	O
of	O	O
20	O	O
tests	O	O
.	O	O
We	O	O
then	O	O
adjusted	O	O
the	O	O
o	O	O
test	O	O
statistics	O	O
to	O	O
correct	O	O
for	O	O
multiple	O	O
comparisons	O	O
using	O	O
F	O	O
of	O	O
<	O	O
0	O	O
.	O	O
Of	O	O
those	O	O
re	O	O
,	O	O
only	O	O
those	O	O
with	O	O
significant	O	O
interaction	O	O
effects	O	O
are	O	O
reported	O	O
.	O	O
Di	O	O
across	O	O
whole	O	O
brain	O	O
networks	O	O
during	O	O
reward	O	O
anticipation	O	O
in	O	O
an	O	O
a	O	O
addiction	O	O
population	O	O
Graphic	O	O
abstract	O	O
Network	O	O
based	O	O
statistics	O	O
(	O	O
N	O	O
)	O	I-E
analyses	O	O
detected	O	O
a	O	O
graph	O	O
sub	O	O
comprising	O	O
153	O	O
edges	O	O
between	O	O
59	O	O
nodes	O	O
of	O	O
the	O	O
connect	O	O
where	O	O
the	O	O
AD	B-SubstanceDisorder	O
group	O	O
demonstrated	O	O
significantly	O	O
less	O	O
connectivity	O	O
compared	O	O
with	O	O
the	O	O
CO	B-SubstanceDisorder	O
group	O	O
.	O	O
These	O	O
differences	O	O
in	O	O
connectivity	O	O
were	O	O
mostly	O	O
in	O	O
(	O	O
55	O	O
)	O	O
,	O	O
the	O	O
majority	O	O
(	O	O
38	O	O
)	O	O
being	O	O
in	O	O
the	O	O
right	O	O
hemisphere	O	O
.	O	O
The	O	O
an	O	O
distribution	O	O
of	O	O
these	O	O
connectivity	O	O
differences	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
involved	O	O
frontal	O	O
(	O	O
ins	O	O
,	O	O
inferior	O	O
frontal	O	O
g	O	O
,	O	O
orbit	O	O
cortex	O	O
)	O	O
,	O	O
limb	O	O
(	O	O
anterior	O	O
c	O	O
g	O	O
,	O	O
th	O	O
)	O	O
,	O	O
and	O	O
s	O	O
(	O	O
a	O	O
,	O	O
ca	O	O
,	O	O
p	O	O
)	O	O
regions	O	O
.	O	O
The	O	O
connectivity	O	O
differences	O	O
reported	O	O
in	O	O
this	O	O
AD	B-SubstanceDisorder	O
sample	O	O
indicate	O	O
alterations	O	O
between	O	O
cognitive	O	O
,	O	O
s	O	O
and	O	O
limb	O	O
regions	O	O
during	O	O
reward	O	O
anticipation	O	O
that	O	O
per	O	O
into	O	O
extended	O	O
a	O	O
.	O	O
High	O	O
Ana	O	O
methods	O	O
can	O	O
capture	O	O
key	O	O
features	O	O
of	O	O
whole	O	O
brain	O	O
networks	O	O
in	O	O
addiction	O	O
.	O	O
We	O	O
compared	O	O
reward	O	O
network	O	O
connectivity	O	O
in	O	O
addiction	B-SubstanceDisorder	O
(	O	O
AD	O	O
)	O	O
and	O	O
control	B-NoKnownDisorder	O
(	O	O
CO	O	O
)	O	O
groups	O	O
.	O	O
The	O	O
AD	B-SubstanceDisorder	B-E
group	O	I-E
showed	O	O
disruption	O	O
in	O	O
global	O	O
network	O	O
connectivity	O	O
.	O	O
Global	O	O
network	O	O
measures	O	O
may	O	O
be	O	O
more	O	O
sensitive	O	O
than	O	O
traditional	O	O
v	O	O
analyses	O	O
.	O	O
The	O	O
prevalent	O	O
spatial	O	O
distribution	O	O
of	O	O
abnormal	O	O
reported	O	O
in	O	O
cognitive	O	O
f	O	O
studies	O	O
in	O	O
addiction	O	O
suggests	O	O
there	O	O
are	O	O
extensive	O	O
disruption	O	O
across	O	O
whole	O	O
brain	O	O
networks	O	O
.	O	O
Studies	O	O
using	O	O
resting	O	B-E
state	O	O
have	O	O
reported	O	O
disruption	O	O
in	O	O
network	O	O
connectivity	O	O
in	O	O
addiction	O	O
,	O	O
but	O	O
these	O	O
studies	O	O
have	O	O
not	O	O
revealed	O	O
characteristics	O	O
of	O	O
network	O	O
functioning	O	O
during	O	O
critical	O	O
psychological	O	O
processes	O	O
that	O	O
are	O	O
disrupted	O	O
in	O	O
addiction	O	O
populations	O	O
.	O	O
Ana	O	O
methods	O	O
that	O	O
can	O	O
capture	O	O
key	O	O
features	O	O
of	O	O
whole	O	O
brain	O	O
networks	O	O
during	O	O
psychological	O	O
processes	O	O
may	O	O
be	O	O
more	O	O
sensitive	O	O
in	O	O
revealing	O	O
additional	O	O
and	O	O
widespread	O	O
neural	O	O
disturbance	O	O
in	O	O
addiction	O	O
,	O	O
that	O	O
are	O	O
the	O	O
provisions	O	O
for	O	O
re	O	O
risk	O	O
,	O	O
and	O	O
targets	O	O
for	O	O
medication	O	O
development	O	O
.	O	O
The	O	O
current	O	O
study	O	O
compared	O	O
a	O	O
substance	O	O
addiction	B-SubstanceDisorder	O
(	O	O
AD	O	O
;	O	O
n	O	O
O	O	O
=	O	O
O	O	O
83	O	O
)	O	O
group	O	O
in	O	O
extended	O	O
a	O	O
with	O	O
a	O	O
control	B-NoKnownDisorder	O
(	O	O
CO	O	O
;	O	O
n	O	O
O	O	O
=	O	O
O	O	O
68	O	O
)	O	O
group	O	O
on	O	O
functional	B-FunctionalMagneticResonanceImaging	O
MR	I-FunctionalMagneticResonanceImaging	O
(	O	O
v	O	O
activation	O	O
)	O	O
and	O	O
global	O	O
network	O	O
(	O	O
connectivity	O	O
)	O	O
measures	O	O
related	O	O
to	O	O
reward	O	O
anticipation	O	O
on	O	O
a	O	O
monetary	O	O
incentive	O	O
delay	O	O
task	O	O
.	O	O
In	O	O
the	O	O
absence	O	O
of	O	O
group	O	O
differences	O	O
on	O	O
MI	O	O
performance	O	O
,	O	O
the	O	O
AD	B-SubstanceDisorder	O
group	O	O
showed	O	O
reduced	O	O
activation	O	O
predominantly	O	O
across	O	O
temporal	O	O
and	O	O
visual	O	O
regions	O	O
,	O	O
but	O	O
not	O	O
across	O	O
the	O	O
s	O	O
.	O	O
The	O	O
AD	B-SubstanceDisorder	O
group	O	O
also	O	O
showed	O	O
disruption	O	O
in	O	O
global	O	O
network	O	O
connectivity	O	O
(	O	O
lower	O	O
cluster	O	O
coefficient	O	O
and	O	O
higher	O	O
characteristic	O	O
path	O	O
length	O	O
)	O	O
,	O	O
and	O	O
significantly	O	O
less	O	O
connectivity	O	O
across	O	O
a	O	O
sub	O	O
comprising	O	O
frontal	O	O
,	O	O
temporal	O	O
,	O	O
limb	O	O
and	O	O
s	O	O
nodes	O	O
.	O	O
These	O	O
results	O	O
show	O	O
that	O	O
an	O	O
addiction	B-SubstanceDisorder	O
group	O	O
in	O	O
extended	O	O
a	O	O
exhibit	O	O
local	O	O
disruption	O	O
in	O	O
brain	O	O
activation	O	O
,	O	O
but	O	O
more	O	O
extensive	O	O
disturbance	O	O
in	O	O
functional	O	O
connectivity	O	O
across	O	O
whole	O	O
brain	O	O
networks	O	O
.	O	O
We	O	O
propose	O	O
that	O	O
measures	O	O
of	O	O
global	O	O
network	O	O
functioning	O	O
may	O	O
be	O	O
more	O	O
sensitive	O	O
in	O	O
highlighting	O	O
late	O	O
and	O	O
more	O	O
widespread	O	O
neural	O	O
disruption	O	O
during	O	O
critical	O	O
psychological	O	O
processes	O	O
in	O	O
addiction	O	O
and	O	O
other	O	O
psychiatric	O	O
disorders	O	O
.	O	O
Material	O	B-E
and	O	I-E
methods	B-StudyMethod	I-E
Part	O	O
Six	O	O
control	B-NoKnownDisorder	I-E
(	O	O
CO	O	O
:	O	O
mean	O	O
age	O	O
39	O	O
O	O	O
±	O	O
O	O	O
1	O	O
;	O	O
18	O	O
females	O	O
,	O	O
50	O	O
males	O	O
)	O	O
and	O	O
83	O	O
addiction	B-SubstanceDisorder	O
(	O	O
AD	O	O
:	O	O
mean	O	O
age	O	O
40	O	O
O	O	O
±	O	O
O	O	O
0	O	O
;	O	O
16	O	O
females	O	O
,	O	O
67	O	O
males	O	O
)	O	O
participants	O	O
completed	O	O
the	O	O
current	O	O
study	O	O
.	O	O
The	O	O
current	O	O
data	O	O
was	O	O
collected	O	O
as	O	O
part	O	O
of	O	O
a	O	O
multi	O	O
study	O	O
involving	O	O
three	O	O
study	O	O
sites	O	O
in	O	O
the	O	O
United	O	O
Kingdom	O	O
(	O	O
Imperial	O	O
College	O	O
London	O	O
,	O	O
University	O	O
of	O	O
Cambridge	O	O
and	O	O
University	O	O
of	O	O
Manchester	O	O
–	O	O
ICC	O	O
)	O	O
.	O	O
For	O	O
a	O	O
more	O	O
detailed	O	O
description	O	O
of	O	O
the	O	O
ICC	O	O
Platform	O	O
,	O	O
see	O	O
)	O	O
and	O	O
.	O	O
Inc	O	O
criteria	O	O
were	O	O
individuals	O	O
who	O	O
met	O	O
DS	O	O
measures	O	O
for	O	O
current	O	O
or	O	O
prior	O	O
substance	O	O
dependence	O	O
(	O	O
e	O	O
.	O	O
,	O	O
alcohol	O	O
,	O	O
cocaine	O	O
,	O	O
op	O	O
)	O	O
.	O	O
The	O	B-E
AD	B-SubstanceDisorder	B-E
group	O	I-E
consisted	O	O
of	O	O
29	O	O
(	O	O
35	O	O
)	O	O
pure	O	B-E
alcohol	O	O
,	O	O
42	O	O
(	O	O
50	O	O
)	O	O
p	O	O
substance	O	O
(	O	O
e	O	O
.	O	O
,	O	O
alcohol	O	O
and	O	O
cocaine	O	O
,	O	O
cocaine	O	O
and	O	O
op	O	O
)	O	O
and	O	O
12	O	O
(	O	O
15	O	O
)	O	O
mon	O	B-E
substance	O	O
(	O	O
e	O	O
.	O	O
,	O	O
cocaine	O	O
,	O	O
op	O	O
)	O	O
volunteers	O	O
.	O	O
While	O	O
addiction	O	O
studies	O	O
typically	O	O
recruit	O	O
volunteers	O	O
in	O	O
early	O	O
a	O	O
,	O	O
there	O	O
was	O	O
no	O	O
upper	O	O
limit	O	O
in	O	O
the	O	O
current	O	O
study	O	O
.	O	O
The	O	O
mean	O	O
a	O	O
length	O	O
from	O	O
alcohol	O	O
in	O	O
the	O	O
current	O	O
sample	O	O
was	O	O
15	O	O
O	O	O
±	O	O
O	O	O
3	O	O
O	O	O
months	O	O
,	O	O
while	O	O
for	O	O
cocaine	O	O
and	O	O
op	O	O
it	O	O
was	O	O
27	O	O
O	O	O
±	O	O
O	O	O
3	O	O
and	O	O
39	O	O
O	O	O
±	O	O
O	O	O
7	O	O
O	O	O
months	O	O
,	O	O
respectively	O	O
.	O	O
Therefore	O	O
,	O	O
the	O	O
current	O	O
AD	O	O
group	O	O
was	O	O
made	O	O
of	O	O
a	O	O
he	O	O
sample	O	O
with	O	O
former	O	O
substance	O	O
,	O	O
and	O	O
with	O	O
variable	O	O
levels	O	O
of	O	O
substance	O	O
a	O	O
at	O	O
the	O	O
time	O	O
of	O	O
testing	O	O
.	O	O
This	O	O
meant	O	O
that	O	O
there	O	O
was	O	O
no	O	O
substance	O	O
dependence	O	O
measure	O	O
that	O	O
was	O	O
shared	O	O
by	O	O
all	O	O
members	O	O
of	O	O
the	O	O
AD	B-SubstanceDisorder	O
group	O	O
.	O	O
The	O	O
CO	B-NoKnownDisorder	B-E
group	O	I-E
had	O	O
no	O	O
previous	O	O
history	O	O
of	O	O
substance	O	O
abuse	O	O
,	O	O
as	O	O
assessed	O	O
using	O	O
the	O	O
Al	B-MentalHealthDiagnosisScale	B-E
,	I-MentalHealthDiagnosisScale	I-E
S	I-MentalHealthDiagnosisScale	I-E
and	I-MentalHealthDiagnosisScale	I-E
Sub	I-MentalHealthDiagnosisScale	I-E
In	I-MentalHealthDiagnosisScale	I-E
Screen	I-MentalHealthDiagnosisScale	I-E
Test	I-MentalHealthDiagnosisScale	I-E
(	I-MentalHealthDiagnosisScale	I-E
AS	I-MentalHealthDiagnosisScale	I-E
)	I-MentalHealthDiagnosisScale	I-E
and	O	O
timeline	O	O
follow	O	O
.	O	O
All	O	O
participants	O	O
were	O	O
required	O	O
to	O	O
provide	O	O
a	O	O
negative	O	O
breath	O	O
alcohol	O	O
test	O	O
and	O	O
a	O	O
negative	O	O
urine	O	O
sample	O	O
for	O	O
various	O	O
drugs	O	O
of	O	O
abuse	O	O
on	O	O
the	O	O
day	O	O
of	O	O
testing	O	O
(	O	O
screening	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
am	O	O
,	O	O
ben	O	O
,	O	O
can	O	O
,	O	O
cocaine	O	O
and	O	O
op	O	O
)	O	O
.	O	O
The	O	O
Mini	B-MentalHealthDiagnosisScale	B-E
N	I-MentalHealthDiagnosisScale	I-E
Interview	I-MentalHealthDiagnosisScale	I-E
(	I-MentalHealthDiagnosisScale	I-E
MI	I-MentalHealthDiagnosisScale	I-E
)	I-MentalHealthDiagnosisScale	I-E
was	O	O
administered	O	O
to	O	O
all	O	O
participants	O	O
by	O	O
a	O	O
trained	O	O
psychiatrist	O	O
to	O	O
screen	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
Axis	O	O
I	O	O
psychiatric	O	O
disorders	O	O
that	O	O
were	O	O
part	O	O
of	O	O
the	O	O
study	O	O
exclusion	O	O
criteria	O	O
.	O	O
Ex	O	O
criteria	O	O
included	O	O
1	O	O
)	O	O
current	O	O
use	O	O
of	O	O
regular	O	O
prescription	O	O
or	O	O
non	O	O
medication	O	O
that	O	O
could	O	O
not	O	O
be	O	O
stopped	O	O
;	O	O
2	O	O
)	O	O
current	O	O
primary	O	O
axis	O	O
I	O	O
diagnosis	O	O
,	O	O
past	O	O
history	O	O
of	O	O
ps	O	O
(	O	O
unless	O	O
drug	O	O
)	O	O
;	O	O
3	O	O
)	O	O
current	O	O
or	O	O
past	O	O
history	O	O
of	O	O
enduring	O	O
severe	O	O
mental	O	O
illness	O	O
(	O	O
e	O	O
.	O	O
,	O	O
s	O	O
,	O	O
bi	O	O
affect	O	O
disorder	O	O
)	O	O
;	O	O
4	O	O
)	O	O
other	O	O
current	O	O
or	O	O
past	O	O
psychiatric	O	O
history	O	O
that	O	O
,	O	O
in	O	O
the	O	O
opinion	O	O
of	O	O
a	O	O
psychiatrist	O	O
,	O	O
con	O	O
participation	O	O
;	O	O
5	O	O
)	O	O
history	O	O
or	O	O
presence	O	O
of	O	O
a	O	O
significant	O	O
ne	O	O
diagnosis	O	O
that	O	O
may	O	O
have	O	O
influenced	O	O
the	O	O
outcome	O	O
or	O	O
analysis	O	O
of	O	O
the	O	O
results	O	O
;	O	O
6	O	O
)	O	O
c	O	O
or	O	O
unable	O	O
to	O	O
lie	O	O
still	O	O
in	O	O
the	O	O
MR	O	O
scan	O	O
for	O	O
up	O	O
to	O	O
90	O	O
O	O	O
min	O	O
and	O	O
7	O	O
)	O	O
presence	O	O
of	O	O
a	O	O
cardiac	O	O
pace	O	O
,	O	O
other	O	O
electronic	O	O
device	O	O
or	O	O
other	O	O
MR	O	O
con	O	O
,	O	O
including	O	O
pregnancy	O	O
,	O	O
as	O	O
assessed	O	O
by	O	O
a	O	O
standard	O	O
pre	O	O
question	O	O
.	O	O
Secondary	O	O
or	O	O
lifetime	O	O
history	O	O
of	O	O
depression	O	O
or	O	O
anxiety	O	O
was	O	O
permitted	O	O
in	O	O
both	O	O
the	O	O
AD	B-Abstinent	O
and	O	O
CO	B-NoKnownDisorder	O
groups	O	O
since	O	O
these	O	O
are	O	O
very	O	O
common	O	O
psychiatric	O	O
disorders	O	O
.	O	O
All	O	O
participants	O	O
provided	O	O
written	O	O
informed	O	O
consent	O	O
.	O	O
The	O	O
study	O	O
was	O	O
conducted	O	O
in	O	O
accordance	O	O
with	O	O
the	O	O
Declaration	O	O
of	O	O
Helsinki	O	O
.	O	O
E	O	O
approval	O	O
was	O	O
obtained	O	O
from	O	O
West	O	O
London	O	O
and	O	O
Gene	O	O
Therapy	O	O
Advisory	O	O
Committee	O	O
National	O	O
Research	O	O
Ethics	O	O
Service	O	O
Committee	O	O
(	O	O
11	O	O
/	O	O
H	O	O
/	O	O
9	O	O
)	O	O
and	O	O
relevant	O	O
research	O	O
governance	O	O
and	O	O
Part	O	O
I	O	O
Centre	O	O
(	O	O
P	O	O
)	O	O
approval	O	O
obtained	O	O
.	O	O
Mon	O	B-E
incentive	O	I-E
delay	O	I-E
task	O	I-E
(	O	I-E
MI	O	I-E
)	O	I-E
We	O	O
used	O	O
a	O	O
“	O	O
monetary	O	O
incentive	O	I-E
delay	O	O
task	O	I-E
”	O	I-E
(	O	O
MI	O	I-E
)	O	O
,	O	O
which	O	O
was	O	O
based	O	O
on	O	O
that	O	O
originally	O	O
employed	O	O
by	O	O
K	O	O
,	O	O
and	O	O
which	O	O
we	O	O
have	O	O
used	O	O
to	O	O
already	O	O
publish	O	O
data	O	O
from	O	O
the	O	O
ICC	O	O
platform	O	O
.	O	O
At	O	O
the	O	O
beginning	O	O
of	O	O
each	O	O
trial	O	O
,	O	O
participants	O	O
viewed	O	O
one	O	O
of	O	O
three	O	O
symbols	O	O
(	O	O
a	O	O
cue	O	O
)	O	O
that	O	O
indicated	O	O
the	O	O
potential	O	O
to	O	O
gain	O	O
fifty	O	O
pen	O	O
(	O	O
square	O	O
containing	O	O
an	O	O
ascending	O	O
arrow	O	O
)	O	O
,	O	O
lose	O	O
fifty	O	O
pen	O	O
(	O	O
square	O	O
containing	O	O
a	O	O
descending	O	O
arrow	O	O
)	O	O
or	O	O
experience	O	O
no	O	O
financial	O	O
outcome	O	O
(	O	O
square	O	O
containing	O	O
a	O	O
horizontal	O	O
line	O	O
-	O	O
here	O	O
referred	O	O
to	O	O
as	O	O
a	O	O
neutral	O	O
trial	O	O
)	O	O
.	O	O
Each	O	O
cue	O	O
was	O	O
presented	O	O
for	O	O
one	O	O
second	O	O
,	O	O
with	O	O
a	O	O
variable	O	O
duration	O	O
(	O	O
2	O	O
–	O	O
4	O	O
O	O	O
s	O	O
)	O	O
for	O	O
the	O	O
subsequent	O	O
anticipation	O	O
period	O	O
.	O	O
Following	O	O
the	O	O
anticipation	O	O
period	O	O
,	O	O
participants	O	O
made	O	O
a	O	O
button	O	O
press	O	O
response	O	O
upon	O	O
the	O	O
presentation	O	O
of	O	O
a	O	O
visual	O	O
target	O	O
(	O	O
star	O	O
located	O	O
within	O	O
a	O	O
circle	O	O
)	O	O
.	O	O
Following	O	O
their	O	O
response	O	O
to	O	O
the	O	O
visual	O	O
target	O	O
,	O	O
participants	O	O
received	O	O
feedback	O	O
(	O	O
1	O	O
O	O	O
s	O	O
)	O	O
as	O	O
to	O	O
whether	O	O
they	O	O
were	O	O
successful	O	O
(	O	O
“	O	O
Hit	O	O
”	O	O
)	O	O
or	O	O
unsuccessful	O	O
(	O	O
“	O	O
Miss	O	O
”	O	O
)	O	O
on	O	O
that	O	O
trial	O	O
and	O	O
saw	O	O
a	O	O
running	O	O
total	O	O
of	O	O
their	O	O
winning	O	O
up	O	O
to	O	O
that	O	O
point	O	O
in	O	O
the	O	O
task	O	O
.	O	O
Following	O	O
feedback	O	O
,	O	O
there	O	O
was	O	O
an	O	O
end	O	O
fix	O	O
period	O	O
(	O	O
3	O	O
–	O	O
5	O	O
O	O	O
s	O	O
)	O	O
before	O	O
the	O	O
commencement	O	O
of	O	O
the	O	O
next	O	O
trial	O	O
.	O	O
Because	O	O
the	O	O
primary	O	O
objective	O	O
of	O	O
ICC	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
neural	O	O
co	O	O
of	O	O
reward	O	O
anticipation	O	O
,	O	O
we	O	O
chose	O	O
to	O	O
use	O	O
a	O	O
smaller	O	O
number	O	O
of	O	O
loss	O	O
trials	O	O
in	O	O
order	O	O
to	O	O
am	O	O
the	O	O
incentive	O	O
sa	O	O
of	O	O
the	O	O
gain	O	O
trials	O	O
during	O	O
the	O	O
task	O	O
.	O	O
Consequently	O	O
,	O	O
there	O	O
was	O	O
a	O	O
total	O	O
of	O	O
18	O	O
gain	O	O
,	O	O
6	O	O
lose	O	O
and	O	O
18	O	O
neutral	O	O
trials	O	O
on	O	O
each	O	O
run	O	O
of	O	O
the	O	O
task	O	O
.	O	O
The	O	O
MI	O	O
task	O	O
was	O	O
tailored	O	O
to	O	O
adapt	O	O
to	O	O
the	O	O
visual	O	O
target	O	O
reaction	O	O
time	O	O
of	O	O
each	O	O
participant	O	O
by	O	O
using	O	O
a	O	O
staircase	O	O
algorithm	O	O
,	O	O
such	O	O
that	O	O
the	O	O
presentation	O	O
of	O	O
the	O	O
visual	O	O
target	O	O
became	O	O
shorter	O	O
as	O	O
performance	O	O
improved	O	O
during	O	O
the	O	O
experiment	O	O
.	O	O
This	O	O
enabled	O	O
us	O	O
to	O	O
set	O	O
a	O	O
limit	O	O
on	O	O
the	O	O
success	O	O
rate	O	O
of	O	O
each	O	O
participant	O	O
(	O	O
[UNK]	O	O
66	O	O
)	O	O
,	O	O
which	O	O
additionally	O	O
served	O	O
to	O	O
in	O	O
participants	O	O
to	O	O
engage	O	O
in	O	O
the	O	O
task	O	O
.	O	O
Part	O	O
were	O	O
instructed	O	O
to	O	O
ma	O	O
their	O	O
winning	O	O
and	O	O
were	O	O
told	O	O
they	O	O
would	O	O
receive	O	O
them	O	O
at	O	O
the	O	O
end	O	O
of	O	O
the	O	O
study	O	O
.	O	O
De	O	O
measures	O	O
were	O	O
accuracy	O	O
(	O	O
percentage	O	O
)	O	O
and	O	O
mean	O	O
reaction	O	O
time	O	O
(	O	O
mill	O	O
)	O	O
to	O	O
the	O	O
visual	O	O
target	O	O
on	O	O
each	O	O
of	O	O
the	O	O
gain	O	O
,	O	O
lose	O	O
and	O	O
neutral	O	O
trials	O	O
,	O	O
and	O	O
the	O	O
amount	O	O
won	O	O
(	O	O
£	O	O
)	O	O
on	O	O
the	O	O
task	O	O
.	O	O
Part	O	O
completed	O	O
two	O	O
runs	O	O
of	O	O
the	O	O
task	O	O
(	O	O
43	O	O
O	O	O
s	O	O
each	O	O
)	O	O
during	O	O
scanning	O	O
.	O	O
The	O	O
task	O	O
was	O	O
programmed	O	O
using	O	O
E	O	O
version	O	O
2	O	O
(	O	O
Psychology	O	O
Software	O	O
Too	O	O
,	O	O
Pittsburgh	O	O
,	O	O
USA	O	O
)	O	O
.	O	O
Statistics	O	O
Group	O	O
demographic	O	O
were	O	O
compared	O	O
using	O	O
simple	O	O
independent	O	O
samples	O	O
t	O	O
analyses	O	O
.	O	O
For	O	O
analyses	O	O
conducted	O	O
on	O	O
MI	O	O
performance	O	O
,	O	O
two	O	O
(	O	O
Group	O	O
:	O	O
CO	O	O
vs	O	O
.	O	O
AD	O	O
)	O	O
by	O	O
two	O	O
(	O	O
Con	O	O
:	O	O
G	O	O
vs	O	O
.	O	O
N	O	O
)	O	O
analyses	O	O
of	O	O
variance	O	O
were	O	O
conducted	O	O
.	O	O
The	O	O
CO	B-NoKnownDisorder	O
and	O	O
AD	B-SubstanceDisorder	O
groups	O	O
were	O	O
also	O	O
compared	O	O
on	O	O
the	O	O
lose	O	O
accuracy	O	O
and	O	O
lose	O	O
reaction	O	O
time	O	O
performance	O	O
measures	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
amount	O	O
of	O	O
money	O	O
won	O	O
(	O	O
£	O	O
)	O	O
,	O	O
using	O	O
analyses	O	O
of	O	O
variance	O	O
.	O	O
These	O	O
analyses	O	O
were	O	O
conducted	O	O
controlling	O	O
for	O	O
study	O	O
site	O	O
.	O	O
For	O	O
the	O	O
graph	O	O
measures	O	O
(	O	O
see	O	O
below	O	O
)	O	O
we	O	O
conducted	O	O
two	O	O
(	O	O
Group	O	O
:	O	O
CO	O	O
vs	O	O
.	O	O
AD	O	O
)	O	O
by	O	O
five	O	O
(	O	O
1	O	O
O	O	O
[UNK]	O	O
O	O	O
K	O	O
O	O	O
[UNK]	O	O
O	O	O
5	O	O
)	O	O
analyses	O	O
of	O	O
variance	O	O
,	O	O
while	O	O
also	O	O
controlling	O	O
for	O	O
study	O	O
site	O	O
.	O	O
All	O	O
these	O	O
analyses	O	O
were	O	O
conducted	O	O
using	O	O
per	O	O
testing	O	O
(	O	O
5000	O	O
it	O	O
)	O	O
in	O	O
the	O	O
R	O	O
statistical	O	O
software	O	O
package	O	O
(	O	O
www	O	O
)	O	O
.	O	O
Fun	B-FunctionalMagneticResonanceImaging	B-E
MR	I-FunctionalMagneticResonanceImaging	I-E
(	I-FunctionalMagneticResonanceImaging	I-E
f	I-FunctionalMagneticResonanceImaging	I-E
)	I-FunctionalMagneticResonanceImaging	O
Data	O	O
acquisition	O	O
The	O	O
ICC	O	O
platform	O	O
was	O	O
designed	O	O
to	O	O
allow	O	O
the	O	O
rapid	O	O
testing	O	O
across	O	O
sites	O	O
of	O	O
multiple	O	O
compounds	O	O
relevant	O	O
to	O	O
addiction	O	O
treatment	O	O
.	O	O
I	O	O
at	O	O
multiple	O	O
sites	O	O
in	O	O
parallel	O	O
on	O	O
the	O	O
ICC	O	O
platform	O	O
accelerated	O	O
study	O	O
completion	O	O
,	O	O
through	O	O
the	O	O
sharing	O	O
of	O	O
expertise	O	O
,	O	O
infrastructure	O	O
and	O	O
capacity	O	O
.	O	O
O	O	O
For	O	O
a	O	O
more	O	O
comprehensive	O	O
description	O	O
of	O	O
data	O	O
acquisition	O	O
across	O	O
the	O	O
three	O	O
sites	O	O
on	O	O
ICC	O	O
,	O	O
please	O	O
see	O	O
M	O	O
et	O	O
al	O	O
.	O	O
B	O	O
,	O	O
all	O	O
centres	O	O
operated	O	O
MR	O	O
machines	O	O
with	O	O
a	O	O
main	O	O
magnetic	O	O
field	O	O
of	O	O
3	O	O
O	O	O
T	O	O
(	O	O
T	O	O
)	O	O
.	O	O
Centre	O	O
in	O	O
London	O	O
and	O	O
Cambridge	O	O
operated	O	O
nominally	O	O
identical	O	O
3	O	O
O	O	O
T	O	O
Siemens	O	O
Tim	O	O
Trio	O	O
systems	O	O
running	O	O
the	O	O
s	O	O
MR	O	O
B	O	O
software	O	O
with	O	O
a	O	O
Siemens	O	O
32	O	O
channel	O	O
receive	O	O
phased	O	O
head	O	O
coil	O	O
.	O	O
The	O	O
Manchester	O	O
centre	O	O
operated	O	O
a	O	O
3	O	O
O	O	O
T	O	O
Philips	O	O
A	O	O
running	O	O
version	O	O
2	O	O
software	O	O
and	O	O
an	O	O
8	O	O
element	O	O
SE	O	O
head	O	O
coil	O	O
.	O	O
